WO2004014325A1 - Cosmetic preparations having two phases - Google Patents

Cosmetic preparations having two phases Download PDF

Info

Publication number
WO2004014325A1
WO2004014325A1 PCT/EP2003/007733 EP0307733W WO2004014325A1 WO 2004014325 A1 WO2004014325 A1 WO 2004014325A1 EP 0307733 W EP0307733 W EP 0307733W WO 2004014325 A1 WO2004014325 A1 WO 2004014325A1
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic
preparation
dermatological
phase
phases
Prior art date
Application number
PCT/EP2003/007733
Other languages
German (de)
French (fr)
Inventor
Rainer Kröpke
Sven Fey
Christel Lemm
Astrid Heptner
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of WO2004014325A1 publication Critical patent/WO2004014325A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/03Liquid compositions with two or more distinct layers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to a two-phase cosmetic and / or dermatological preparation and its use.
  • the skin is the largest organ in humans. Among its many functions (for example for heat regulation and as a sensory organ), the barrier function that prevents the skin (and ultimately the entire organism) from drying out is probably the most important. At the same time, the skin acts as a protective device against the penetration and absorption of substances coming from outside. This barrier function is brought about by the epidermis, which as the outermost layer forms the actual protective cover against the environment. At around a tenth of the total thickness, it is also the thinnest layer of the skin.
  • Skin care products usually creams, ointments or lotions, mostly serve to moisturize and regrease the skin. Active ingredients that regenerate the skin and, for example, prevent and reduce its premature aging (for example the appearance of wrinkles, wrinkles) are often added to them.
  • sunscreen care products usually consist of emulsions.
  • Emulsions are generally understood to mean heterogeneous systems which consist of two immiscible or only to a limited extent miscible liquids, which are usually referred to as phases and in which one of the two liquids is dispersed in the form of very fine droplets in the other liquid. When viewed externally and with the naked eye, emulsions appear homogeneous.
  • the two liquids are water and oil and if there are oil droplets dispersed in water, it is an oil-in-water emulsion (O / W emulsion, e.g. milk).
  • O / W emulsion oil-in-water emulsion
  • the basic character of an O / W emulsion is characterized by the water.
  • a water-in-oil emulsion (W / O emulsion, e.g. butter) is the reverse principle, whereby the basic character is determined by the oil.
  • So-called emulsifiers are added to the emulsions in order to keep emulsions stable over a longer period of time and to prevent separation of the phases.
  • Emulsifiers are usually molecules with a polar, hydrophilic
  • Each emulsifier is assigned a so-called HLB value (a dimensionless number between 0 and 20), which indicates whether there is a preferred water or oil solubility. Numbers below 9 indicate oil-soluble, hydrophobic emulsifiers, numbers above
  • Cosmetic and / or dermatological formulations generally represent externally uniform, homogeneous preparations. However, consumers are increasingly perceiving them as monotonous and boring. However, the possibilities for making these preparations more visually attractive are limited. Increasingly, consumers are also tired of the flood of ready-to-use finished products and are inspired by the desire to prepare the cosmetic formulations themselves and then do themselves "something good”. In order to accommodate this new zest for action by consumers, two-phase cosmetic preparations are becoming increasingly popular offered, which the customer can convert into a homogeneous emulsion by simply shaking and then use. To give the customer the pleasure of "mixing" before each use allow, the homogeneous emulsion must separate again in a reasonable time. This is the only way to match the play instinct of consumers and guarantee the joy of use. Last but not least, the two-phase products enable completely new optical design options.
  • two-phase cosmetic and / or dermatological preparation comprising a) an aqueous phase comprising i) one or more alcohols in an amount of at least 50% by weight, based on the total weight of the preparation and ii) one or more alkali and / or alkaline earth metal salts of organic and / or inorganic acids in an amount of 0.01 to 6% by weight, based on the total weight of the preparation b) a lipid phase whose interfacial tension is at least 30 Nm / m, in addition to any further cosmetic and / or dermatological Active ingredients, auxiliaries and additives.
  • phase denotes a liquid component of the overall preparation which appears to be uniform with the naked eye and is separated from a second layer by a phase boundary which is visible to the naked eye.
  • phase boundary which is visible to the naked eye.
  • the invention is carried out under the homogenization of the preparation Shaking understood that after shaking the entire preparation appears visually to the naked eye as a uniform preparation without visible phase boundaries.
  • the lipophilic phase contains no constituents which have a solubilizer or emulsifier property.
  • Such compounds include, for example, silicone oils or partial fatty acid esters (mono- and diglycerides) such as cocoglyceride.
  • the emulsion according to the invention may as an aqueous' phase in addition to water according to the invention other ingredients include, for example, alcohols, diols (for example 1, 2-propanediol) or polyols of low C number, and their ethers, preferably propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or - monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analog products, polymers, electrolytes, dihydoxyacetone and in particular one or more thickeners, which or soft ones can advantageously be selected from the group consisting of silicon dioxide and aluminum silicates, Polysaccharides or their derivatives, e.g.
  • one or more alcohols are advantageously selected from the group consisting of ethanol, 1-propanol and 2-propanol.
  • the alcohol preferred according to the invention is ethanol.
  • the preparation according to the invention contains at least 50% by weight of alcohol, based on the total weight of the preparation, wherein at least 50% by weight according to the invention means that the preparation contains 50% by weight or more than 50% by weight of alcohol can.
  • the preparation preferably contains at least 55% by weight and particularly preferably 60% by weight of alcohol, in each case based on the total weight of the preparation.
  • one or more alkali and / or alkaline earth metal salts of organic and / or inorganic acids are selected from the group consisting of magnesium chloride, sodium chloride, potassium chloride, calcium chloride, magnesium chloride and sea salt.
  • Magnesium sulfate is the preferred salt according to the invention.
  • the salts according to the invention can of course also be used in the form of their hydrates.
  • the aqueous phase advantageously contains ethanol in a concentration of 50 to 90% by weight, preferably in a concentration of 55 to 75% by weight and very particularly preferably in a concentration of 55 to 60% by weight, in each case based on the total weight of the Preparation.
  • the aqueous phase advantageously contains glycerol in a concentration of 1 to 20% by weight, preferably in a concentration of 3 to 12% by weight and very particularly preferably in a concentration of 5 to 10% by weight, in each case based on the total weight of the Preparation.
  • Moisturizers can also be used with preference. Moisturizers are substances or mixtures of substances that give cosmetic or dermatological preparations the property of reducing the release of moisture from the horny layer (also called transepidermal water loss (TEWL)) after application or distribution on the skin surface and / or positively hydrating the horny layer to influence.
  • TEWL transepidermal water loss
  • moisturizers for the purposes of the present invention are, for example, glycerin, lactic acid and / or lactates, in particular sodium octate, butylene glycol, propylene glycol, biosaccaride gum-1, glycine soya, ethylhexyloxyglycerol, pyrrolidone carboxylic acid and urea. Furthermore, it is particularly advantageous to use polymeric moisturizers from the group of water-soluble and / or water-swellable and / or water-gelable polysaccharides.
  • the lipid phase of the formulations according to the invention is advantageously selected from the group of polar oils, for example from the group of lecithins and fatty acid triglycerides, in particular the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12 to 18 carbon atoms.
  • the fatty acid triglycerides can for example be advantageously selected from the group of synthetic, semisynthetic and natural oils, such as. B.
  • z. B natural waxes of animal and vegetable origin, such as beeswax and other insect waxes and berry wax, shea butter and / or lanolin (wool wax).
  • further advantageous polar oil components can also be selected from the group of esters from saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms and from the group of esters from aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms.
  • ester oils can then advantageously be selected from the group octyl palmitate, octyl co-coat, octyl isostearate, octyl dodeceyl myristate, octyl dodecanol, cetearyl isononanoate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-stonolate, n-stonolate, n-stonyl-n-stonate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyalpalmitate, stearyl heptanoate, oleyl oleate, olerlerucate, erucyioleate, erucylerucate
  • the lipid phase can advantageously be selected from the group of dialkyl ethers and dialkyl carbonates.
  • the oil component (s) from the group isoeikosan, neopentyl glycol diheptanoate, propylene glycol dicaprylate dicaprate, caprylic / capric / diglyceryl succinate, butylene glycol dicaprylate / dicaprate, cocoglycerides (e.g. Myritol® C 12 from Henkel) 13 alkyl lactate, di-C 12 ⁇ 3 alkyl tartrate, triisostearin, dipentaerythrityl hexacaprylate / hexacaprate, propylene glycol monoisostearate, tncaprylin, dimethyl isosorbide. It is particularly advantageous if the lipid phase of the formulations according to the invention comprises 12 5 -alkyl . ⁇ a content of C or consists entirely of this.
  • Advantageous oil components are also e.g. B. butyl octyl salicylate (for example that available under the trade name Hallbrite BHB from CP Hall), hexadecyl benzoate and butyl octyl benzoate and mixtures thereof (Hallstar AB) and / or diethyl hexyl naphthalate ⁇ Hallbrite TQ from CP Hall or Corapan®TQ from Haarmann & Reimer).
  • B. butyl octyl salicylate for example that available under the trade name Hallbrite BHB from CP Hall
  • hexadecyl benzoate and butyl octyl benzoate and mixtures thereof Hallstar AB
  • diethyl hexyl naphthalate ⁇ Hallbrite TQ from CP Hall or Corapan®TQ from Haarmann & Reimer
  • the lipid phase can also advantageously also contain non-polar oils, for example those which are selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, petroleum jelly (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes and isohexa- decane.
  • non-polar oils for example those which are selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, petroleum jelly (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes and isohexa- decane.
  • polyolefins polydecenes are the preferred substances.
  • the lipid phase advantageously contains dicaprylyl carbonate in a concentration of 5 to 50% by weight, preferably in a concentration of 15 to 30% by weight and very particularly preferably in a concentration of 18 to 22% by weight, in each case based on the total weight of the preparation ,
  • the lipid phase caprylic / capric contains triglycerides in a concentration of 0 to 50% by weight, preferably in one Concentration of 1 to 20% by weight and very particularly preferably in a concentration of 3 to 10% by weight, in each case based on the total weight of the preparation.
  • the lipid phase advantageously contains C12-C15 alkyl benzoates in a concentration of 0 to 50% by weight, preferably in a concentration of 1 to 20% by weight and very particularly preferably in a concentration of 3 to 8% by weight, in each case based on the total weight of the preparation.
  • the lipid phase advantageously contains isoeicosan in a concentration of 0 to 50% by weight, preferably in a concentration of 1 to 20% by weight and very particularly preferably in a concentration of 7 to 12% by weight, in each case based on the total weight of the preparation ,
  • the expert can set the interfacial tension of the lipid phase in an obvious way by mixing the individual lipid components, their interfacial tension from standard tables such as Landold-Börnstein (Springer-Verlag), Handbook of Chemistry and Physics (CRC press) or the manufacturer's information for the individual components can be removed.
  • volume ratio of aqueous phase to lipid phase is from 50:50 to 90:10 and particularly preferably from 60:40 to 75:25.
  • the preparations according to the invention can contain cosmetic and / or dermatological active ingredients, auxiliaries and additives, as are usually used in such preparations, e.g. B. preservatives, preservation aids, bactericides, perfumes, repellents, self-tanners, depigmenting agents, substances to prevent foaming, dyes, pigments that have a coloring effect, thickening agents, moisturizing and / or moisturizing substances, fillers that improve the feeling on the skin.
  • Advantageous preservatives for the purposes of the present invention are, for example, formaldehyde releasers (such as, for example, DMDM hydantoin, which, for example, are listed under the trade name Glydant TM is available from Lonza), iodopropylbutyl carbamate (for example those available under the trade names Glycacil-L, Glycacil-S from Lonza and / or Dekaben LMB from Jan Dekker), parabens ( ie p-hydroxybenzoic acid alkyl esters, such as methyl, ethyl, propyl and / or butyl paraben), phenoxyethanol, ethanol, benzoic acid and the like.
  • the preservation system usually also advantageously comprises preservation aids, such as, for example, octoxyglycerol, glycine soya, etc.
  • the aqueous and / or the lipid phase can advantageously be colored with one or more water- or lipid-soluble dyes.
  • compositions are also obtained if antioxidants are used as additives or active ingredients.
  • the preparations advantageously contain one or more antioxidants. All of the antioxidants suitable or customary for cosmetic and / or dermatological applications can be used as inexpensive, but nevertheless optional, antioxidants.
  • water-soluble antioxidants such as vitamins, e.g. B. ascorbic acid and its derivatives.
  • Preferred antioxidants are also vitamin E and its derivatives and vitamin A and its derivatives.
  • the amount of the antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 0.1 to 10% by weight, based on the total weight the preparation.
  • vitamin E and / or its derivatives represent the antioxidant (s)
  • vitamin A or vitamin A derivatives or carotenes or their derivatives represent the antioxidant or antioxidants, it is advantageous to determine their respective concentrations from the range from 0.001 to 10 wt .-%, based on the total weight of the formulation to choose.
  • the cosmetic preparations according to the present invention contain cosmetic or dermatological active ingredients, preferred active ingredients being antioxidants which can protect the skin from oxidative stress.
  • active substances in the sense of the present invention are natural active substances and / or their derivatives, such as.
  • Recipes according to the invention which, for. B. known anti-wrinkle agents such as flavone glycosides (especially ⁇ -glycosylrutin), coenzyme Q10, vitamin E and / or derivatives and the like, are particularly advantageous for the prophylaxis and treatment of cosmetic or dermatological skin changes such as z. B. occur with skin aging (such as dryness, roughness and formation of dry lines, itching, reduced re-greasing (e.g. after washing), visible vasodilation (telangiectasia, cuperosis), flaccidity and formation of wrinkles and fine lines, local hyper- , Hypo and incorrect pigmentation (e.g. age spots), increased susceptibility to mechanical stress (e.g. cracking) and the like). They are also advantageous against the appearance of dry or rough skin.
  • skin aging such as dryness, roughness and formation of dry lines, itching, reduced re-greasing (e.g. after washing), visible vasodilation (telangiec
  • compositions according to the invention include, for example, panthenol, allantoin, tannin, antihistamines, antiphlogistics, glucocorticoids (e.g. hydrocortisone) as well as plant substances such as azulene and bisabolol, glycyrrhizin, hamamelin and plant extracts such as chamomile, aloe vera, hamazelis, licorice root.
  • glucocorticoids e.g. hydrocortisone
  • plant substances such as azulene and bisabolol, glycyrrhizin, hamamelin and plant extracts such as chamomile, aloe vera, hamazelis, licorice root.
  • the preparation according to the invention can advantageously be used as a sunscreen. But it is also advantageous in the sense of the present invention, cosmetic and to create dermatological preparations whose main purpose is not to protect against sunlight, but which nevertheless contain other UV protection substances. So z.
  • UV-A or UV-B filter substances are usually incorporated into self-tanning products, day care products or make-up products. UV protection substances, like antioxidants and, if desired, preservatives, also provide effective protection of the preparations themselves against spoilage.
  • the preparations within the meaning of the present invention advantageously contain at least one UV-A, UV-B and / or broadband filter substance and / or at least one inorganic pigment reflecting and / or absorbing UV light.
  • the formulation may, although not necessary, optionally also contain one or more organic and / or inorganic pigments as UV filter substances, which may be present in the water and / or the oil phase
  • UV protective substances are exclusively in one of the two phases or in both phases of the preparation according to the invention.
  • Preferred inorganic pigments are metal oxides and / or other metal compounds which are sparingly soluble or insoluble in water, in particular oxides of titanium (TiO 2 ), zinc (ZnO), iron (e.g. Fe 2 O 3 ), zirconium (ZrO 2 ), silicon ( SiO 2 ), manganese (e.g. MnO), Aluminum (Al 2 O 3 ), cerium (e.g. Ce 2 O 3 ), mixed oxides of the corresponding metals as well as mixtures of such oxides and the sulfate of barium (BaSO 4 ).
  • the pigments can also advantageously be used in the form of commercially available oily or aqueous predispersions. Dispersing aids and / or solubilizing agents can advantageously be added to these predispersions.
  • the pigments can advantageously be surface-treated ("coated"), for example, a hydrophilic, amphiphilic or hydrophobic character should be formed or retained.
  • This surface treatment can consist in that the pigments are prepared using a thin hydrophilic and / or hydrophobic inorganic and / or organic layer
  • the various surface coatings can also contain water in the sense of the present invention.
  • Inorganic surface coatings in the sense of the present invention can consist of aluminum oxide (Al 2 O 3 ), aluminum hydroxide Al (OH) 3 , or aluminum oxide hydrate (also: alumina, CAS no .: 1333-84-2), sodium hexa etaphosphate (NaPO 3 ) 6 , sodium metaphosphate (NaPO 3 ) n , silicon dioxide (SiO 2 ) (also: silica, CAS No .: 7631-86-9), barium sulfate (BaSO 4 ) or iron oxide (Fe 2 O 3 ).
  • Al 2 O 3 aluminum oxide
  • Al (OH) 3 aluminum hydroxide Al
  • aluminum oxide hydrate also: alumina, CAS no .: 1333-84-2
  • sodium hexa etaphosphate (NaPO 3 ) 6 sodium metaphosphate (NaPO 3 ) n
  • silicon dioxide SiO 2
  • SiSO 4 barium sulfate
  • Fe 2 O 3 iron
  • Organic surface coatings in the sense of the present invention can consist of vegetable or animal aluminum stearate, vegetable or animal stearic acid, lauric acid, dimethylpolysiloxane (also: dimethicone), methylpolysiloxane (methicone), simethicone (a mixture of dimethylpolysiloxane with an average chain length of 200 to 350 dimethylsiloxane Units and silica gel) or alginic acid.
  • dimethylpolysiloxane also: dimethicone
  • methicone methylpolysiloxane
  • simethicone a mixture of dimethylpolysiloxane with an average chain length of 200 to 350 dimethylsiloxane Units and silica gel
  • alginic acid can consist of vegetable or animal aluminum stearate, vegetable or animal stearic acid, lauric acid, dimethylpolysiloxane (also: dimethicone), methylpolysiloxan
  • Zinc oxide particles and predispersions of zinc oxide particles suitable according to the invention are available under the following trade names from the listed companies:
  • Suitable titanium dioxide particles and predispersions of titanium dioxide particles are available under the following trade names from the companies listed:
  • UV-A filter substances for the purposes of the present invention are dibenzoyl methane derivatives, in particular 4- (tert-butyl) -4'-methoxydibenzoyl methane (CAS No. 70356-09-1), which is available from Givaudan under the Parsol brand ® 1789 and is sold by Merck under the trade name Eusolex® 9020.
  • dibenzoyl methane derivatives in particular 4- (tert-butyl) -4'-methoxydibenzoyl methane (CAS No. 70356-09-1), which is available from Givaudan under the Parsol brand ® 1789 and is sold by Merck under the trade name Eusolex® 9020.
  • UV filter substances for the purposes of the present invention are sulfonated, water-soluble UV filters, such as, for. B .:
  • Idenmethyl-10-sulfonic acid is called Benzene-1,4-di (2-oxo-3-bomylidenemethyl-10-sulfonic acid) has the INCI name terephthalic the dicampher sulfonic acid (CAS No. 90457-82-2) and is available, for example, from the company Chimex under the trade name Mexoryl SX;
  • Sulfonic acid derivatives of 3-benzylidene camphor such as. B. 4- (2-oxo-3-bornylidene-methyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bomylidene-methyl) sulfonic acid and salts thereof.
  • Hydroxybenzophenone derivatives such as e.g. 2- (4-Diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester, which is available, for example, from BASF under the
  • Benzoxazole derivatives such as e.g. the 2,4-bis- [5-1 (dimethylpropyl) benzossazol-2-yl- (4-phenyl) imino] -6- (2-ethylhexyl) imino-1,3,5-triazine (CAS no .: 288254-16-0), which is available, for example, from 3V Sigma under the trade name UVASorb® K2A.
  • Advantageous UV filter substances in the sense of the present invention are also so-called broadband filters, i.e. Filter substances that absorb both UV-A and UV-B radiation.
  • Advantageous broadband filters or UV-B filter substances are, for example, triazine derivatives, such as. B.
  • Diethylhexylbutylamidotriazon (INCI: Diethylhexylbutamidotriazone), which is available under the trade name UVASORB HEB from Sigma 3V;
  • An advantageous broadband filter in the sense of the present invention is also the 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol ), which is available under the trade name Tinosorb® M from CIBA-Chemicals GmbH.
  • Another advantageous broadband filter for the purposes of the present invention is 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1.3 l 3,3-tetramethyl-1- [(trimethylsilyl) oxy] disiloxa- nyöpropylj-phenol (CAS no .: 155633-54-8) with the INCI name Drometrizole Trisiloxane, which is available under the trade name Mexoryl® XL from Chimex.
  • the other UV filter substances can be oil-soluble or water-soluble.
  • Advantageous oil-soluble UV-B and / or broadband filter substances in the sense of the present invention are e.g. B .:
  • 3-benzylidene camphor derivatives preferably 3- (4-methylbenzylidene) camphor, 3-benzylidene camphor, ⁇ 4-aminobenzoic acid derivatives, preferably 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester, 4- (dimethylamino) benzoic acid amyl ester,
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone
  • Particularly advantageous preparations within the meaning of the present invention which are distinguished by a high or very high UV-A and / or UV-B protection, preferably contain further UV-A and in addition to the filter substance (s) according to the invention / or broadband filter, in particular dibenzoylmethane derivatives [for example the 4- (tert-butyl) -4'-methoxydibenzoylmethane], phenylene-1,4, bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid and / or their salts, the 2- (4-diethylamino-2- hydroxybenzoyl) benzoic acid hexyl ester and / or the 2,4-bis - ⁇ [4- (2-ethylhexyloxy) -2-hydroxy] phenyl ⁇ -6- (4-methoxyphenyl) -1,3,5- triazine and / or the 2- (4-diethylamino-2-hydroxybenz
  • UV filters mentioned, which can be used in the sense of the present invention, should of course not be limiting.
  • the UV light protection filters advantageous according to the invention are preferably used in a concentration of 0.1 to 30% by weight, in particular in a concentration of 0.5 to 15% by weight, based on the total weight of the formulation:
  • Particularly preferred embodiments of the present invention contain, as the UV filter, one or more triazine derivatives, dibenzoylmethane derivatives, UV filters which are liquid at room temperature and / or the inorganic pigments, in particular titanium dioxide.
  • film formers may also be advantageous to incorporate film formers into the preparation according to the invention, for example in order to improve the water resistance of the preparations or to increase the UV protection performance (UV-A and / or UV-B boosting).
  • Both water-soluble or dispersible and fat-soluble film formers are suitable, in each case individually or in combination with one another.
  • Advantageous fat-soluble film formers are e.g. B., the film formers from the group of polymers based on polyvinylpyrrolidone (PVP)
  • copolymers of polyvinylpyrrolidone for example the PVP hexadecene copolymer and the PVP eicosen copolymer, which are available under the trade names Antaron V216 and Antaron V220 from GAF Chemicals Cooperation, as well as Tricontayl PVP and the like.
  • the method for adjusting the separation speed of a two-phase cosmetic and / or dermatological preparation homogenized by shaking according to the invention is characterized in that the difference in density of the two phases is varied by the addition of a) one or more alcohols to the aqueous phase, thereby reducing their density is reduced, b) one or more alkali and / or alkaline earth metal salts of organic and / or inorganic acids to the aqueous phase, which increases their density, c) mineral oils, dicaprylyl ether and / or octyldodecanol to the lipophilic phase, which reduces their density, and / or d) Caprylic-capric triglyceride, C12-15 alkyl benzoates, dicarylyl carbonates and / or triisostearin, whereby the density of the lipophilic phase is increased, a lower density difference resulting in an increase in the separation rate.
  • the separation speed is understood to mean the time which the preparation homogenized by shaking takes to visually separate into two phases separated from one another by a clear phase boundary, visually visible to the naked eye.
  • the separation speed is at least 1 minute and a maximum of 45 minutes.
  • a density difference of 2 to 6% corresponds to a separation speed of approx. 1 to 15 minutes and a density difference of 0.1 to 2% corresponds to a separation speed of approx. 15 to 45 minutes.
  • the use of one or more alcohols in cosmetic and / or dermatological preparations according to the invention is advantageous Extension of the separation speed in two phases after homogenization of the preparation by shaking.
  • the use of one or more alkali and / or alkaline earth metal salts of organic and / or inorganic acids in cosmetic and / or dermatological preparations according to the invention to shorten the separation speed in two phases after the homogenization of the preparation by shaking.
  • the use of mineral oils, dicaprylyl ether and / or octyldodecanol in cosmetic and / or dermatological preparations according to the invention is also used to extend the separation rate in two phases after the preparation has been homogenized by shaking.
  • caprylic-capric triglyceride and / or triisostearin in cosmetic and / or dermatological preparations according to the invention is also used to shorten the separation speed in two phases after the preparation has been homogenized by shaking,
  • cosmetic and / or dermatological preparations according to the invention for the care of the skin and skin appendages (e.g. the hair, nails) is advantageous.
  • the use of the preparations according to the invention for cooling and refreshing the skin is preferred.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to a two-phase cosmetic and/or dermatological preparation comprising a) an aqueous phase containing i) at least one alcohol in a quantity of at least 50 wt. %, in relation to the total weight of the preparation, and ii) at least one alkali salt and/or alkaline earth salt of organic and/or inorganic acids in a quantity of between 0.01 and 6 wt. %, in relation to the entire weight of the preparation, and b) a lipid phase having an interfacial tension of at least 30 Nm/m, in addition to optionally other cosmetic and/or dermatological active ingredients, auxiliary agents and additives. The invention also relates to the uses of alcohols, mineral oils, dicaprylyl ether and/or octyl dodecanol, for reducing the speed of separation into two phases after homogenisation by means of shaking. The invention further relates to the use of salts of organic and/or inorganic acids, caprylic-capric acid triglyceride, C12-15 alkyl benzoate, dicaprylyl carbonate and/or triisostearin, for reducing the speed of separation.

Description

Kosmetische Zubereitungen mit zwei Phasen Cosmetic preparations with two phases
Die vorliegende Erfindung betrifft eine zweiphasige kosmetische und/oder dermatologische Zubereitung und Ihre Verwendung.The present invention relates to a two-phase cosmetic and / or dermatological preparation and its use.
Der Wunsch, schön und attraktiv auszusehen, ist von Natur aus im Menschen verwurzelt. Auch wenn das Schönheitsideal im Laufe der Zeit Wandlungen erfahren hat, so ist -das Streben nach einem makellosen Äußeren immer das Ziel der Menschen gewesen. Einen wesentlichen Anteil an einem schönen und attraktiven Äußeren hat dabei der Zustand und das Aussehen der Haut.The desire to look beautiful and attractive is inherently rooted in people. Even if the ideal of beauty has changed over time, the pursuit of a flawless appearance has always been the goal of people. The condition and appearance of the skin has a significant part in a beautiful and attractive exterior.
Die Haut ist das größte Organ des Menschen. Unter ihren vielen Funktionen (beispielsweise zur Wärmeregulation und als Sinnesorgan) ist die Barrierefunktion, die das Austrocknen der Haut (und damit letztlich des gesamten Organismus) verhindert, die wohl wichtigste. Gleichzeitig wirkt die Haut als Schutzeinrichtung gegen das Eindringen und die Aufnahme von außen kommender Stoffe. Bewirkt wird diese Barrierefunktion durch die Epidermis, welche als äußerste Schicht die eigentliche Schutzhülle gegenüber der Umwelt bildet. Mit etwa einem Zehntel der Gesamtdicke ist sie gleichzeitig die dünnste Schicht der Haut.The skin is the largest organ in humans. Among its many functions (for example for heat regulation and as a sensory organ), the barrier function that prevents the skin (and ultimately the entire organism) from drying out is probably the most important. At the same time, the skin acts as a protective device against the penetration and absorption of substances coming from outside. This barrier function is brought about by the epidermis, which as the outermost layer forms the actual protective cover against the environment. At around a tenth of the total thickness, it is also the thinnest layer of the skin.
Damit die Haut ihre biologischen Funktionen im vollen Umfang erfülien kann, bedarf sie der regelmäßigen Reinigung und Pflege sowie dem Schutz vor UV-Strahlung. Die Reinigung der Haut dient dabei der Entfernung von Schmutz, Schweiß und Resten abgestorbener Hautpartikel, die einen idealen Nährboden für Krankheitserreger und Parasiten aller Art bilden. Hautpflegeprodukte, in der Regel Cremes, Salben oder Lotionen, dienen meist der Befeuchtung und Rückfettung der Haut. Häufig sind ihnen Wirkstoffe zugesetzt, welche die Haut regenerieren und beispielsweise ihre vorzeitige Alterung (z.B. das Entstehen von Fältchen, Falten) verhindern und vermindern sollen. Zum Schutz vor der schädlichen UV-Strahlung des Sonnenlichtes sind vielen kosmetischen und dermatologischen Hautpflegeprodukten UV-Lichtschutzfilter zugesetzt. Hautpflegeprodukte bestehen in der Regel aus Emulsionen. Unter Emulsionen versteht man im allgemeinen heterogene Systeme, die aus zwei nicht oder nur begrenzt miteinander mischbaren Flüssigkeiten bestehen, die üblicherweise als Phasen bezeichnet werden und bei denen eine der beiden Flüssigkeiten in Form feinster Tröpfchen in der anderen Flüssigkeit dispergiert ist. Äußerlich und mit bloßem Auge betrachtet erscheinen Emulsionen homogen.In order for the skin to fully fulfill its biological functions, it needs regular cleaning and care as well as protection against UV radiation. The cleaning of the skin serves to remove dirt, sweat and residues of dead skin particles, which form an ideal breeding ground for pathogens and parasites of all kinds. Skin care products, usually creams, ointments or lotions, mostly serve to moisturize and regrease the skin. Active ingredients that regenerate the skin and, for example, prevent and reduce its premature aging (for example the appearance of wrinkles, wrinkles) are often added to them. To protect against the harmful UV radiation from sunlight, many cosmetic and dermatological skin care products have UV protection filters added. Skin care products usually consist of emulsions. Emulsions are generally understood to mean heterogeneous systems which consist of two immiscible or only to a limited extent miscible liquids, which are usually referred to as phases and in which one of the two liquids is dispersed in the form of very fine droplets in the other liquid. When viewed externally and with the naked eye, emulsions appear homogeneous.
Sind die beiden Flüssigkeiten Wasser und öl und liegen öltröpfchen fein verteilt in Wasser vor, so handelt es sich um eine ÖI-in-Wasser-Emulsion (O/W-Emulsion, z. B. Milch). Der Grundcharakter einer O/W-Emulsion ist durch das Wasser geprägt. Bei einer Wasser-in-öl-Emulsion (W/O-Emulsion, z. B. Butter) handelt es sich um das umgekehrte Prinzip, wobei der Grundcharakter hier durch das öl bestimmt wird.If the two liquids are water and oil and if there are oil droplets dispersed in water, it is an oil-in-water emulsion (O / W emulsion, e.g. milk). The basic character of an O / W emulsion is characterized by the water. A water-in-oil emulsion (W / O emulsion, e.g. butter) is the reverse principle, whereby the basic character is determined by the oil.
Um Emulsionen über einen längeren Zeitraum stabil zu halten und eine Entmischung der Phasen zu verhindern, werden den Emulsionen sogenannte Emulgatoren zugesetzt. BeiSo-called emulsifiers are added to the emulsions in order to keep emulsions stable over a longer period of time and to prevent separation of the phases. at
Emulgatoren handelt es sich in der Regel um Moleküle mit einem polaren, hydrophilenEmulsifiers are usually molecules with a polar, hydrophilic
Strukturelement und einem unpolaren, lipophilen Strukturelement. Ende der vierzigerStructural element and a non-polar, lipophilic structural element. Late forties
Jahre wurde ein System entwickelt, das die Auswahl von Emulgatoren erleichtern sollte.Years a system was developed that should facilitate the selection of emulsifiers.
Jedem Emulgator wird ein sogenannter HLB-Wert (eine dimensionslose Zahl zwischen 0 und 20) zugeschrieben, der angibt, ob eine bevorzugte Wasser- oder öllöslichkeit vorliegt. Zahlen unter 9 kennzeichnen öllösliche, hydrophobe Emulgatoren, Zahlen überEach emulsifier is assigned a so-called HLB value (a dimensionless number between 0 and 20), which indicates whether there is a preferred water or oil solubility. Numbers below 9 indicate oil-soluble, hydrophobic emulsifiers, numbers above
11 wasserlösliche, hydrophile.11 water-soluble, hydrophilic.
Kosmetische und/oder .dermatologische Formulierungen stellen also in der Regel äußerlich einheitliche, homogene Zubereitungen dar. Diese werden jedoch von den Verbrauchern zunehmend als eintönig und langweilig empfunden. Die Möglichkeiten, diese Zubereitungen optisch attraktiver zu gestalten sind allerdings begrenzt. In zunehmendem Maße sind die Verbraucher auch der Flut direkt applizierbarer Fertigprodukte überdrüssig und von dem Wunsch beseelt, sich die kosmetischen Formulierungen selbst zuzubereiten um sich anschließend „etwas Gutes" zu tun. Um diesem neuartigen Tatendrang der Verbraucher entgegen zu kommen, werden zunehmend zweiphasige kosmetische Zubereitungen angeboten, die der Kunde durch einfaches Schütteln in eine homogene Emulsion überführen und anschließend anwenden kann. Um den Kunden die Freude am „selber mixen" vor jeder Anwendung zu ermöglichen, muss sich die homogene Emulsion allerdings in angemessener Zeit wieder entmischen. Nur so kann dem Spieltrieb der Verbraucher entsprochen und die Freude an der Anwendung gewährleistet werden. Nicht zuletzt ermöglichen die zweiphasigen Produkte völlig neuartige optische Gestaltungsmöglichkeiten.Cosmetic and / or dermatological formulations generally represent externally uniform, homogeneous preparations. However, consumers are increasingly perceiving them as monotonous and boring. However, the possibilities for making these preparations more visually attractive are limited. Increasingly, consumers are also tired of the flood of ready-to-use finished products and are inspired by the desire to prepare the cosmetic formulations themselves and then do themselves "something good". In order to accommodate this new zest for action by consumers, two-phase cosmetic preparations are becoming increasingly popular offered, which the customer can convert into a homogeneous emulsion by simply shaking and then use. To give the customer the pleasure of "mixing" before each use allow, the homogeneous emulsion must separate again in a reasonable time. This is the only way to match the play instinct of consumers and guarantee the joy of use. Last but not least, the two-phase products enable completely new optical design options.
Es war daher die Aufgabe der vorliegenden Erfindung die Mängel des Standes der Technik zu beseitigen und ein Hautpflegeprodukt zu entwickeln, das aus zwei optisch unterscheidbaren Phasen besteht, die sich durch einfaches Schütteln homogenisieren lassen, wobei sich die homogenisierte Zubereitung in einem Zeitraum von maximal 45 Minuten wieder vollständig in die beiden Ausgangsphasen entmischen sollte. Darüber hinaus sollte in der Zubereitung weitgehend auf den Einsatz von Emulgatoren verzichtet werden. Grundsätzlich ist der Einsatz von Emulatoren in kosmetischen Zubereitungen unbedenklich, doch können Emulgatoren, wie letztlich jede chemische Verbindung, in Einzelfällen bei besonders sensiblen Menschen Allergien oder Hautreizungen auslösen, weshalb die Bereitstellung von weitgehend emulgatorfreien kosmetischen und dermatologischen Zubereitungen für einen derartigen Personenkreis einen nicht unerheblichen Fortschritt darstellt.It was therefore the object of the present invention to remedy the shortcomings of the prior art and to develop a skin care product which consists of two optically distinguishable phases which can be homogenized by simple shaking, the homogenized preparation being able to take place within a maximum period of 45 minutes should completely separate again into the two initial phases. In addition, the use of emulsifiers should largely be avoided in the preparation. In principle, the use of emulators in cosmetic preparations is harmless, but emulsifiers, like ultimately any chemical compound, can cause allergies or skin irritation in particularly sensitive people in individual cases, which is why the provision of largely emulsifier-free cosmetic and dermatological preparations for such a group of people is a not inconsiderable advance represents.
Überraschend gelöst wird die Aufgabe durch zweiphasige kosmetische und/oder dermatologische Zubereitung enthaltend a) eine wässrige Phase enthaltend i) ein oder mehrere Alkohole in einer Menge von mindestens 50 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung und ii) ein oder mehrere Alkali- und/oder Erdalkalisalze organischer und/oder anorganischer Säuren in einer Menge von 0,01 bis 6 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung b) eine Lipidphase deren Grenzflächenspannung mindestens 30 Nm/m beträgt, neben gegebenenfalls weiteren kosmetischen und/oder dermatologischen Wirk-, Hilfs- und Zusatzstoffen.The object is surprisingly achieved by two-phase cosmetic and / or dermatological preparation comprising a) an aqueous phase comprising i) one or more alcohols in an amount of at least 50% by weight, based on the total weight of the preparation and ii) one or more alkali and / or alkaline earth metal salts of organic and / or inorganic acids in an amount of 0.01 to 6% by weight, based on the total weight of the preparation b) a lipid phase whose interfacial tension is at least 30 Nm / m, in addition to any further cosmetic and / or dermatological Active ingredients, auxiliaries and additives.
Erfindungsgemäß wird dabei unter dem Begriff Phase ein optisch mit bloßem Auge einheitlich erscheinender und durch eine mit bloßem Auge sichtbare Phasengrenze von einer zweiten Schicht abgegrenzter flüssiger Bestandteil der Gesamtzubereitung bezeichnet. Erfindungsgemäß wird unter der Homogenisierung der Zubereitung durch Schütteln verstanden, dass die Gesamtzubereitung nach dem Schütteln optisch mit bloßem Auge als eine einheitliche Zubereitung ohne sichtbare Phasengrenzen erscheint.According to the invention, the term phase denotes a liquid component of the overall preparation which appears to be uniform with the naked eye and is separated from a second layer by a phase boundary which is visible to the naked eye. According to the invention is carried out under the homogenization of the preparation Shaking understood that after shaking the entire preparation appears visually to the naked eye as a uniform preparation without visible phase boundaries.
Es ist erfindungsgemäß besonders vorteilhaft und in den meisten Fällen sogar zwingend erforderlich, dass die lipophile Phase keine Bestandteile enthält, die eine Lösungsvermittler- bzw. Emulgatoreigenschaft aufweisen. Zu derartigen Verbindungen zählen beispielsweise Silikonöle oder Partialfettsäureester (Mono- und Diglyceride) wie beispielsweise Cocoglycerid.According to the invention, it is particularly advantageous and in most cases even imperative that the lipophilic phase contains no constituents which have a solubilizer or emulsifier property. Such compounds include, for example, silicone oils or partial fatty acid esters (mono- and diglycerides) such as cocoglyceride.
Die erfindungsgemäße Emulsion kann als wässrige ' Phase neben Wasser erfindungsgemäß auch andere Inhaltsstoffe enthalten, beispielsweise Alkohole, Diole (z.B. 1, 2-Propandiol) oder Polyole niedriger C-Zahl, sowie deren Ether, vorzugsweise Propylenglykol, Glycerin, Ethylenglykol, Ethylenglykolmonoethyl- oder -monobutylether, Propylenglykolmonomethyl, -monoethyl- oder -monobutylether, Diethy- lenglykolmonomethyl- oder -monoethylether und analoge Produkte, Polymere, Elek- trolyte, Dihydoxyaceton sowie insbesondere ein oder mehrere Verdickungsmittel, welches oder weiche vorteilhaft gewählt werden können aus der Gruppe Siliciumdioxid, Aluminiumsilikate, Polysaccharide bzw. deren Derivate, z. B. Hyaluronsäure, Xanthangummi, Hydroxypropylmethylcellulose, besonders vorteilhaft aus der Gruppe der Polyacrylate, bevorzugt ein Polyacrylat aus der Gruppe der sogenannten Carbopole, beispielsweise Carbopole der Typen 980, 981, 1382, 2984, 5984, jeweils einzeln oder in Kombination.The emulsion according to the invention may as an aqueous' phase in addition to water according to the invention other ingredients include, for example, alcohols, diols (for example 1, 2-propanediol) or polyols of low C number, and their ethers, preferably propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or - monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analog products, polymers, electrolytes, dihydoxyacetone and in particular one or more thickeners, which or soft ones can advantageously be selected from the group consisting of silicon dioxide and aluminum silicates, Polysaccharides or their derivatives, e.g. B. hyaluronic acid, xanthan gum, hydroxypropylmethyl cellulose, particularly advantageously from the group of polyacrylates, preferably a polyacrylate from the group of so-called carbopoles, for example carbopoles of types 980, 981, 1382, 2984, 5984, each individually or in combination.
Erfindungsgemäß vorteilhaft werden ein oder mehrere Alkohole gewählt aus der Gruppe Ethanol, 1-Propanol, 2-Propanol. Der erfindungsgemäß bevorzugte Alkohol ist Ethanol.According to the invention, one or more alcohols are advantageously selected from the group consisting of ethanol, 1-propanol and 2-propanol. The alcohol preferred according to the invention is ethanol.
Auch ist es erfindungsgemäß vorteilhaft, wenn die erfindungsgemäße Zubereitung mindestens 50 Gewichts-% Alkohol, bezogen auf das Gesamtgewicht der Zubereitung enthält, wobei mindestens 50 Gewichts-% erfindungsgemäß bedeutet, dass die Zubereitung 50 Gewichts-% oder mehr als 50 Gewichts-% Alkohol enthalten kann. Erfindungsgemäß bevorzugt enthält die Zubereitung mindestens 55 Gewichts-% und besonders bevorzugt 60 Gewichts-% Alkohol, jeweils bezogen auf das Gesamtgewicht der Zubereitung. Bei einem erfindungsgemäß vorteilhaften Alkohol-Gehalt von mindestens 50 Gewichts-% kann erfindungsgemäß vorteilhaft auf Konservierungsmittel verzichtet werden, was einen weiteren Vorzug der vorliegenden Erfindung darstellt.It is also advantageous according to the invention if the preparation according to the invention contains at least 50% by weight of alcohol, based on the total weight of the preparation, wherein at least 50% by weight according to the invention means that the preparation contains 50% by weight or more than 50% by weight of alcohol can. According to the invention, the preparation preferably contains at least 55% by weight and particularly preferably 60% by weight of alcohol, in each case based on the total weight of the preparation. With an alcohol content of at least 50% by weight which is advantageous according to the invention, preservatives can advantageously be dispensed with according to the invention, which represents a further advantage of the present invention.
Es ist ferner eriϊndungsgemäß von Vorteil, wenn ein oder mehrere Alkali- und/oder Erdalkalisalze organischer und/oder anorganischer Säuren gewählt werden aus der Gruppe Magnesiumchlorid, Natriumchlorid, Kaliumchlorid, Calciumchlorid, Magnesiumchlorid, Meersalz. Dabei ist Magnesiumsulfat das erfindungsgemäß bevorzugte Salz. Selbstverständlich können die erfindungsgemäßen Salze auch in Form ihrer Hydrate eingesetzt werden.It is also advantageous according to the invention if one or more alkali and / or alkaline earth metal salts of organic and / or inorganic acids are selected from the group consisting of magnesium chloride, sodium chloride, potassium chloride, calcium chloride, magnesium chloride and sea salt. Magnesium sulfate is the preferred salt according to the invention. The salts according to the invention can of course also be used in the form of their hydrates.
Erfindungsgemäß vorteilhaft enthält die wässrige Phase Ethanol in einer Konzentration von 50 bis 90 Gewichts-%, bevorzugt in einer Konzentration von 55 bis 75 Gewichts-% und ganz besonders bevorzugt in einer Konzentration von 55 bis 60 Gewichts-%, jeweils bezogen auf das Gesamtgewicht der Zubereitung.According to the invention, the aqueous phase advantageously contains ethanol in a concentration of 50 to 90% by weight, preferably in a concentration of 55 to 75% by weight and very particularly preferably in a concentration of 55 to 60% by weight, in each case based on the total weight of the Preparation.
Erfindungsgemäß vorteilhaft enthält die wässrige Phase Glycerin in einer Konzentration von 1 bis 20 Gewichts-%, bevorzugt in einer Konzentration von 3 bis 12 Gewichts-% und ganz besonders bevorzugt in einer Konzentration von 5 bis 10 Gewichts-%, jeweils bezogen auf das Gesamtgewicht der Zubereitung.According to the invention, the aqueous phase advantageously contains glycerol in a concentration of 1 to 20% by weight, preferably in a concentration of 3 to 12% by weight and very particularly preferably in a concentration of 5 to 10% by weight, in each case based on the total weight of the Preparation.
Auch Moisturizer können bevorzugt verwendet werden. Als Moisturizer werden Stoffe oder Stoffgemische bezeichnet, welche kosmetischen oder dermatologischen Zubereitungen die Eigenschaft verleihen, nach dem Auftragen bzw. Verteilen auf der Hautoberfläche die Feuchtigkeitsabgabe der Hornschicht (auch transepidermal water loss (TEWL) genannt) zu reduzieren und/oder die Hydratation der Hornschicht positiv zu beeinflussen.Moisturizers can also be used with preference. Moisturizers are substances or mixtures of substances that give cosmetic or dermatological preparations the property of reducing the release of moisture from the horny layer (also called transepidermal water loss (TEWL)) after application or distribution on the skin surface and / or positively hydrating the horny layer to influence.
Vorteilhafte Moisturizer im Sinne der vorliegenden Erfindung sind beispielsweise Glyce- rin, Milchsäure und/oder Lactate, insbesondere Natriumiactat, Butylenglykol, Propylen- glykol, Biosaccaride Gum-1, Glycine Soja, Ethylhexyloxyglycerin, Pyrrolidoncarbonsäure und Harnstoff. Ferner ist es insbesondere von Vorteil, polymere Moisturizer aus der Gruppe der wasserlöslichen und/oder in Wasser quellbaren und/oder mit Hilfe von Wasser gelierbaren Polysaccharide zu verwenden. Insbesondere vorteilhaft sind beispiels- weise Hyaluronsäure, Chitosan und/oder ein fucosereiches Polysaccharid, welches in den Chemical Abstracts unter der Registraturnummer 178463-23-5 abgelegt und z. B. unter der Bezeichnung Fucogel®1000 von der Gesellschaft SOLABIA S.A. erhältlich ist.Advantageous moisturizers for the purposes of the present invention are, for example, glycerin, lactic acid and / or lactates, in particular sodium octate, butylene glycol, propylene glycol, biosaccaride gum-1, glycine soya, ethylhexyloxyglycerol, pyrrolidone carboxylic acid and urea. Furthermore, it is particularly advantageous to use polymeric moisturizers from the group of water-soluble and / or water-swellable and / or water-gelable polysaccharides. Particularly advantageous are as hyaluronic acid, chitosan and / or a fucose-rich polysaccharide, which is filed in the Chemical Abstracts under the registration number 178463-23-5 and z. B. is available under the name Fucogel®1000 from the company SOLABIA SA.
Die Lipidphase der erfindungsgemäßen Formulierungen wird vorteilhaft gewählt aus der Gruppe der polaren öle, beispielsweise aus der Gruppe der Lecithine und der Fettsäure- triglyceride, namentlich der Triglycerinester gesättigter und/oder ungesättigter, verzweigter und/oder unverzweigter Alkancarbonsäuren einer Kettenlänge von 8 bis 24, insbesondere 12 bis 18 C-Atomen. Die Fettsäuretriglyceride können beispielsweise vorteilhaft gewählt werden aus der Gruppe der synthetischen, halbsynthetischen und natürlichen öle, wie z. B. Olivenöl, Sonnenblumenöl, Sojaöl, Erdnußöl, Rapsöl, Mandelöl, Palmöl, Kokosöl, Rizinusöl, Weizenkeimöl, Traubenkernöl, Distelöl, Nachtkerzenöl, Macadamia- nußöl und dergleichen mehr.The lipid phase of the formulations according to the invention is advantageously selected from the group of polar oils, for example from the group of lecithins and fatty acid triglycerides, in particular the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12 to 18 carbon atoms. The fatty acid triglycerides can for example be advantageously selected from the group of synthetic, semisynthetic and natural oils, such as. B. olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grape seed oil, safflower oil, evening primrose oil, macadamia nut oil and the like.
Erfindungsgemäß vorteilhaft sind ferner z. B. natürliche Wachse tierischen und pflanzlichen Ursprungs, wie beispielsweise Bienenwachs und andere Insektenwachse sowie Beerenwachs, Sheabutter und/oder Lanolin (Wollwachs).According to the invention, z. B. natural waxes of animal and vegetable origin, such as beeswax and other insect waxes and berry wax, shea butter and / or lanolin (wool wax).
Weitere vorteilhafte polare ölkomponenten können im Sinne der vorliegenden Erfindung ferner gewählt werden aus der Gruppe der Ester aus gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten Alkancarbonsäuren einer Kettenlänge von 3 bis 30 C-Atomen und gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten Alkoholen einer Kettenlänge von 3 bis 30 C-Atomen sowie aus der Gruppe der Ester aus aromatischen Carbonsäuren und gesättigten und/oder ungesättigten, Verzweigten und/oder unverzweigten Alkoholen einer Kettenlänge von 3 bis 30 C-Atomen. Solche Esteröle können dann vorteilhaft gewählt werden aus der Gruppe Octylpalmitat, Octylco- coat, Octylisostearat, Octyldodeceylmyristat, Octyldodekanol, Cetearylisononanoat, Isopropylmyristat, Isopropylpalmitat, Isopropylstearat, Isopropyloleat, n-Butylstearat, n- Hexyllaurat, n-Decyloleat, Isooctylstearat, Isononylstearat, Isononylisononanoat, 2-Ethyl- hexylpalmitat, 2-Ethylhexyllaurat, 2-Hexyldecylstearat, 2-OctyldodecyIpalmitat, Stearyl- heptanoat, Oleyloleat, Oleylerucat, Erucyioleat, Erucylerucat, Tridecylstearat, Tridecyltri- mellitat, sowie synthetische, halbsynthetische und natürliche Gemische solcher Ester, wie z. B. Jojobaöl. Ferner kann die Lipidphase vorteilhaft gewählt werden aus der Gruppe der Dialkylether und Dialkylcarbonate, vorteilhaft sind z. B. Dicaprylylether (Cetiol OE) und/oder Dicaprylylcarbonat, beispielsweise das unter der Handelsbezeichnung Cetiol CC bei der Fa. Cognis erhältliche.For the purposes of the present invention, further advantageous polar oil components can also be selected from the group of esters from saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms and from the group of esters from aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms. Such ester oils can then advantageously be selected from the group octyl palmitate, octyl co-coat, octyl isostearate, octyl dodeceyl myristate, octyl dodecanol, cetearyl isononanoate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-stonolate, n-stonolate, n-stonyl-n-stonate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyalpalmitate, stearyl heptanoate, oleyl oleate, olerlerucate, erucyioleate, erucylerucate, tridecyl stearate, tridecyltrimetic and natural gemellate, as well as synthetic, such as. B. Jojoba oil. Furthermore, the lipid phase can advantageously be selected from the group of dialkyl ethers and dialkyl carbonates. B. dicaprylyl ether (Cetiol OE) and / or dicaprylyl carbonate, for example that available under the trade name Cetiol CC from Cognis.
Es ist ferner bevorzugt, das oder die Ölkomponenten aus der Gruppe Isoeikosan, Neo- pentylglykoldiheptanoat, Propylenglykoldicaprylat dicaprat, Caprylic/Capric/Diglyceryl- succinat, Butylenglykol Dicaprylat/Dicaprat, Cocoglyceride (z. B. Myritol® 331 von Henkel), C12-13-Alkyllactat, Di-C12-ι3-Alkyltartrat, Triisostearin, Dipentaerythrityl Hexa- caprylat/Hexacaprat, Propylenglykolmonoisostearat, Tncaprylin, Dimethylisosorbid. Es ist insbesondere vorteilhaft, wenn die Lipidphase der erfindungsgemäßen Formulierungen einen Gehalt an C125-Alkylbenzoat aufweist oder vollständig aus diesem besteht.It is further preferred that the oil component (s) from the group isoeikosan, neopentyl glycol diheptanoate, propylene glycol dicaprylate dicaprate, caprylic / capric / diglyceryl succinate, butylene glycol dicaprylate / dicaprate, cocoglycerides (e.g. Myritol® C 12 from Henkel) 13 alkyl lactate, di-C 12 ι 3 alkyl tartrate, triisostearin, dipentaerythrityl hexacaprylate / hexacaprate, propylene glycol monoisostearate, tncaprylin, dimethyl isosorbide. It is particularly advantageous if the lipid phase of the formulations according to the invention comprises 12 5 -alkyl .ι a content of C or consists entirely of this.
Vorteilhafte Ölkomponenten sind ferner z. B. Butyloctylsalicylat (beispielsweise das unter der Handelsbezeichnung Hallbrite BHB bei der Fa. CP Hall erhältliche), Hexadecylben- zoat und Butyloctylbenzoat und Gemische davon (Hallstar AB) und/oder Diethylhexyl- naphthalat {Hallbrite TQ von CP Hall oder Corapan®TQvon Haarmann & Reimer).Advantageous oil components are also e.g. B. butyl octyl salicylate (for example that available under the trade name Hallbrite BHB from CP Hall), hexadecyl benzoate and butyl octyl benzoate and mixtures thereof (Hallstar AB) and / or diethyl hexyl naphthalate {Hallbrite TQ from CP Hall or Corapan®TQ from Haarmann & Reimer).
Auch beliebige Abmischungen solcher öl- und Wachskomponenten sind vorteilhaft im Sinne der vorliegenden Erfindung einzusetzen.Any mixtures of such oil and wax components can also be used advantageously for the purposes of the present invention.
Ferner kann die Lipidphase ebenfalls vorteilhaft auch unpolare öle enthalten, beispielsweise solche, welche gewählt werden aus der Gruppe der verzweigten und unverzweigten Kohlenwasserstoffe und -wachse, insbesondere Mineralöl, Vaseline (Petrolatum), Paraffinöl, Squalan und Squalen, Polyolefine, hydrogenierte Polyisobutene und Isohexa- decan. Unter den Polyolefinen sind Polydecene die bevorzugten Substanzen.Furthermore, the lipid phase can also advantageously also contain non-polar oils, for example those which are selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, petroleum jelly (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes and isohexa- decane. Among the polyolefins, polydecenes are the preferred substances.
Erfindungsgemäß vorteilhaft enhält die Lipidphase Dicaprylylcarbonat in einer Konzentration von 5 bis 50 Gewichts-%, bevorzugt in einer Konzentration von 15 bis 30 Gewichts-% und ganz besonders bevorzugt in einer Konzentration von 18 bis 22 Gewichts-%, jeweils bezogen auf das Gesamtgewicht der Zubereitung.According to the invention, the lipid phase advantageously contains dicaprylyl carbonate in a concentration of 5 to 50% by weight, preferably in a concentration of 15 to 30% by weight and very particularly preferably in a concentration of 18 to 22% by weight, in each case based on the total weight of the preparation ,
Erfindungsgemäß vorteilhaft enthält die Lipidphase Caprylic/Capric (Capryl-Caprinäure) Triglyceride in einer Konzentration von 0 bis 50 Gewichts-%, bevorzugt in einer Konzentration von 1 bis 20 Gewichts-% und ganz besonders bevorzugt in einer Konzentration von 3 bis 10 Gewichts-%, jeweils bezogen auf das Gesamtgewicht der Zubereitung.Advantageously according to the invention, the lipid phase caprylic / capric (caprylic-capric acid) contains triglycerides in a concentration of 0 to 50% by weight, preferably in one Concentration of 1 to 20% by weight and very particularly preferably in a concentration of 3 to 10% by weight, in each case based on the total weight of the preparation.
Erfindungsgemäß vorteilhaft enthält die Lipidphase C12-C15 Alkyl Benzoate in einer Konzentration von 0 bis 50 Gewichts-%, bevorzugt in einer Konzentration von 1 bis 20 Gewichts-% und ganz besonders bevorzugt in einer Konzentration von 3 bis 8 Gewichts- %, jeweils bezogen auf das Gesamtgewicht der Zubereitung.According to the invention, the lipid phase advantageously contains C12-C15 alkyl benzoates in a concentration of 0 to 50% by weight, preferably in a concentration of 1 to 20% by weight and very particularly preferably in a concentration of 3 to 8% by weight, in each case based on the total weight of the preparation.
Erfindungsgemäß vorteilhaft enthält die Lipidphase Isoeicosan in einer Konzentration von 0 bis 50 Gewichts-%, bevorzugt in einer Konzentration von 1 bis 20 Gewichts-% und ganz besonders bevorzugt in einer Konzentration von 7 bis 12 Gewichts-%, jeweils bezogen auf das Gesamtgewicht der Zubereitung.According to the invention, the lipid phase advantageously contains isoeicosan in a concentration of 0 to 50% by weight, preferably in a concentration of 1 to 20% by weight and very particularly preferably in a concentration of 7 to 12% by weight, in each case based on the total weight of the preparation ,
Die Einstellung der Grenzflächenspannung der Lipidphase gelingt dem Fachmann in naheliegender Weise durch das Mischen der einzelnen Lipidkomponenten, deren Grenzflächenspannung aus Standarttabellenwerken wie beispielsweise dem Landold- Börnstein (Springer-Verlag), Handbook of Chemitry and Physics (CRC press) oder den Herstellerinformationen für die Einzelkomponenten entnommen werden kann.The expert can set the interfacial tension of the lipid phase in an obvious way by mixing the individual lipid components, their interfacial tension from standard tables such as Landold-Börnstein (Springer-Verlag), Handbook of Chemistry and Physics (CRC press) or the manufacturer's information for the individual components can be removed.
Es ist Vorteilhaft im Sinne der vorliegenden Erfindung, wenn das Volumenverhältnis von wässriger Phase zu Lipidphase von 50 : 50 bis 90 : 10 und besonders bevorzugt von 60 : 40 bis 75 : 25 beträgt.It is advantageous in the sense of the present invention if the volume ratio of aqueous phase to lipid phase is from 50:50 to 90:10 and particularly preferably from 60:40 to 75:25.
Die erfindungsgemäßen Zubereitungen können kosmetische und/oder dermatologische Wirk-, Hilfs- und Zusatzstoffe enthalten, wie sie üblicherweise in solchen Zubereitungen verwendet werden, z. B. Konservierungsmittel, Konseryierungshelfer, Bakterizide, Parfüme, Repellentien, Selbtbräuner, Depigmentierungsmittel, Substanzen zum Verhindern des Schäumens, Farbstoffe, Pigmente, die eine färbende Wirkung haben, Ver- dickungsmittel, anfeuchtende und/oder feuchhaltende Substanzen, Füllstoffe, die das Hautgefühl verbessern.The preparations according to the invention can contain cosmetic and / or dermatological active ingredients, auxiliaries and additives, as are usually used in such preparations, e.g. B. preservatives, preservation aids, bactericides, perfumes, repellents, self-tanners, depigmenting agents, substances to prevent foaming, dyes, pigments that have a coloring effect, thickening agents, moisturizing and / or moisturizing substances, fillers that improve the feeling on the skin.
Vorteilhafte Konservierungsmittel im Sinne der vorliegenden Erfindung sind beispielsweise Formaldehydabspalter (wie z. B. DMDM Hydantoin, welches beispielsweise unter der Handelsbezeichnung Glydant ™ von der Fa. Lonza erhältlich ist), lodopropylbutyl- carbamate (z. B. die unter den Handelsbezeichnungen Glycacil-L, Glycacil-S von der Fa. Lonza erhältlichen und/oder Dekaben LMB von Jan Dekker), Parabene (d. h. p-Hydroxy- benzoesäurealkylester, wie Methyl-, Ethyl-, Propyl- und/oder Butylparaben), Phenoxy- ethanol, Ethanol, Benzoesäure und dergleichen mehr. Üblicherweise umfaßt das Konservierungssystem erfindungsgemäß ferner vorteilhaft auch Konservierungshelfer, wie beispielsweise Octoxyglycerin, Glycine Soja etc.Advantageous preservatives for the purposes of the present invention are, for example, formaldehyde releasers (such as, for example, DMDM hydantoin, which, for example, are listed under the trade name Glydant ™ is available from Lonza), iodopropylbutyl carbamate (for example those available under the trade names Glycacil-L, Glycacil-S from Lonza and / or Dekaben LMB from Jan Dekker), parabens ( ie p-hydroxybenzoic acid alkyl esters, such as methyl, ethyl, propyl and / or butyl paraben), phenoxyethanol, ethanol, benzoic acid and the like. According to the invention, the preservation system usually also advantageously comprises preservation aids, such as, for example, octoxyglycerol, glycine soya, etc.
Erfindungsgemäß vorteilhaft kann die wässrige und/oder die Lipidphase mit einem oder mehreren wasser- bzw. lipidlöslichen Farbstoffen eingefärbt sein.According to the invention, the aqueous and / or the lipid phase can advantageously be colored with one or more water- or lipid-soluble dyes.
Besonders vorteilhafte Zubereitungen werden ferner erhalten, wenn als Zusatz- oder Wirkstoffe Antioxidantien eingesetzt werden. Erfindungsgemäß enthalten die Zubereitungen vorteilhaft eines oder mehrere Antioxidantien. Als günstige, aber dennoch fakultativ zu verwendende Antioxidantien können alle für kosmetische und/oder dermatologische Anwendungen geeigneten oder gebräuchlichen Antioxidantien verwendet werden.Particularly advantageous preparations are also obtained if antioxidants are used as additives or active ingredients. According to the invention, the preparations advantageously contain one or more antioxidants. All of the antioxidants suitable or customary for cosmetic and / or dermatological applications can be used as inexpensive, but nevertheless optional, antioxidants.
Besonders vorteilhaft im Sinne der vorliegenden Erfindung können wasserlösliche Antioxidantien eingesetzt werden, wie beispielsweise Vitamine, z. B. Ascorbinsäure und de- ren Derivate.For the purposes of the present invention, water-soluble antioxidants, such as vitamins, e.g. B. ascorbic acid and its derivatives.
Bevorzugte Antioxidantien sind ferner Vitamin E und dessen Derivate sowie Vitamin A und dessen Derivate.Preferred antioxidants are also vitamin E and its derivatives and vitamin A and its derivatives.
Die Menge der Antioxidantien (eine oder mehrere Verbindungen) in den Zubereitungen beträgt vorzugsweise 0,001 bis 30 Gew.-%, besonders bevorzugt 0,05 bis 20 Gew.-%, insbesondere 0,1 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung.The amount of the antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 0.1 to 10% by weight, based on the total weight the preparation.
Sofern Vitamin E und/oder dessen Derivate das oder die Antioxidantien darstellen, ist vorteilhaft, deren jeweilige Konzentrationen aus dem Bereich von 0,001 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen.If vitamin E and / or its derivatives represent the antioxidant (s), it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation.
Sofern Vitamin A bzw. Vitamin-A-Derivate, bzw. Carotine bzw. deren Derivate das oder die Antioxidantien darstellen, ist vorteilhaft, deren jeweilige Konzentrationen aus dem Be- reich von 0,001 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen.If vitamin A or vitamin A derivatives or carotenes or their derivatives represent the antioxidant or antioxidants, it is advantageous to determine their respective concentrations from the range from 0.001 to 10 wt .-%, based on the total weight of the formulation to choose.
Es ist insbesondere vorteilhaft, wenn die kosmetischen Zubereitungen gemäß der vorlie- genden Erfindung kosmetische oder dermatologische Wirkstoffe enthalten, wobei bevorzugte Wirkstoffe Antioxidantien sind, welche die Haut vor oxidativer Beanspruchung schützen können.It is particularly advantageous if the cosmetic preparations according to the present invention contain cosmetic or dermatological active ingredients, preferred active ingredients being antioxidants which can protect the skin from oxidative stress.
Weitere vorteilhafte Wirkstoffe im Sinne der vorliegenden Erfindung sind natürliche Wirk- Stoffe und/oder deren Derivate, wie z. B. alpha-Liponsäure, Phytoen, D-Biotin, Coenzym Q10, alpha-Glucosylrutin, Camitin, Camosin, natürliche und/oder synthetische Isoflavo- noide, Kreatin, Taurin und/oder ß-Alanin.Further advantageous active substances in the sense of the present invention are natural active substances and / or their derivatives, such as. B. alpha-lipoic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, camitin, camosin, natural and / or synthetic isoflavonoids, creatine, taurine and / or ß-alanine.
Erfindungsgemäße Rezepturen, welche z. B. bekannte Antifaltenwirkstoffe wie Flavon- glycoside (insbesondere σ-Glycosylrutin), Coenzym Q10, Vitamin E und/oder Derivate und dergleichen enthalten, eignen sich insbesondere vorteilhaft zur Prophylaxe und Behandlung kosmetischer oder dermatologischer Hautveränderungen, wie sie z. B. bei der Hautalterung auftreten (wie beispielsweise Trockenheit, Rauhigkeit und Ausbildung von Trockenheitsfältchen, Juckreiz, verminderte Rückfettung (z. B. nach dem Waschen), sichtbare Gefäßerweiterungen (Teleangiektasien, Cuperosis), Schlaffheit und Ausbildung von Falten und Fältchen, lokale Hyper-, Hypo- und Fehlpigmentierungen (z. B. Altersflecken), vergrößerte Anfälligkeit gegenüber mechanischem Stress (z. B. Rissigkeit) und dergleichen). Weiterhin vorteilhaft eignen sie sich gegen das Erscheinungsbild der trockenen bzw. rauhen Haut.Recipes according to the invention, which, for. B. known anti-wrinkle agents such as flavone glycosides (especially σ-glycosylrutin), coenzyme Q10, vitamin E and / or derivatives and the like, are particularly advantageous for the prophylaxis and treatment of cosmetic or dermatological skin changes such as z. B. occur with skin aging (such as dryness, roughness and formation of dry lines, itching, reduced re-greasing (e.g. after washing), visible vasodilation (telangiectasia, cuperosis), flaccidity and formation of wrinkles and fine lines, local hyper- , Hypo and incorrect pigmentation (e.g. age spots), increased susceptibility to mechanical stress (e.g. cracking) and the like). They are also advantageous against the appearance of dry or rough skin.
In die erfindungsgemäßen Zubereitungen können aber auch andere pharmazeutisch oder dermatologisch wirkende Substanzen wie beispielsweise die Haut beruhigende und pflegende Substanzen eingearbeitet sein. Hierzu zählen beispielsweise Panthenol, Allantoin, Tannin, Antihistaminika, Antiphlogistika, Glucocorticoide (z.B. Hydrocortison) sowie Pflanzenwirkstoffe wie Azulen und Bisabolol, Glycyrrhizin, Hamamelin und Pflanzenextrakte wie Kamille, aloe vera, Hamazelis, Süßholzwurzel.However, other pharmaceutically or dermatologically active substances such as, for example, substances that soothe and care for the skin can also be incorporated into the preparations according to the invention. These include, for example, panthenol, allantoin, tannin, antihistamines, antiphlogistics, glucocorticoids (e.g. hydrocortisone) as well as plant substances such as azulene and bisabolol, glycyrrhizin, hamamelin and plant extracts such as chamomile, aloe vera, hamazelis, licorice root.
Die erfindungsgemäße Zubereitung kann vorteilhaft als Sonnenschutzmittel eingesetzt werden. Es ist aber auch vorteilhaft im Sinne der vorliegenden Erfindung, kosmetische und dermatologische Zubereitungen zu erstellen, deren hauptsächlicher Zweck nicht der Schutz vor Sonnenlicht ist, die aber dennoch einen Gehalt an weiteren UV-Schutzsubstanzen enthalten. So werden z. B. in Selbstbräunungsprodukten, Tagespflegeprodukten oder Make-up-Produkten gewöhnlich UV-A- bzw. UV-B-Filtersub- stanzen eingearbeitet. Auch stellen UV-Schutzsubstanzen, ebenso wie Antioxidantien und, gewünschtenfalls Konservierungsstoffe, einen wirksamen Schutz der Zubereitungen selbst gegen Verderb dar.The preparation according to the invention can advantageously be used as a sunscreen. But it is also advantageous in the sense of the present invention, cosmetic and to create dermatological preparations whose main purpose is not to protect against sunlight, but which nevertheless contain other UV protection substances. So z. For example, UV-A or UV-B filter substances are usually incorporated into self-tanning products, day care products or make-up products. UV protection substances, like antioxidants and, if desired, preservatives, also provide effective protection of the preparations themselves against spoilage.
Dementsprechend enthält die Zubereitungen im Sinne der vorliegenden Erfindung vor- teilhaft mindestens eine UV-A-, UV-B- und/oder Breitbandfiltersubstanz und/oder mind. ein UV-Licht reflektierendes und/oder absorbierendes anorganisches Pigment. Die Formulierung kann, obgleich nicht notwendig, gegebenenfalls auch ein oder mehrere organische und/oder anorganische Pigmente als UV-Filtersubstanzen enthalten, welche in der Wasser- und/oder der Ölphase vorliegen könnenAccordingly, the preparations within the meaning of the present invention advantageously contain at least one UV-A, UV-B and / or broadband filter substance and / or at least one inorganic pigment reflecting and / or absorbing UV light. The formulation may, although not necessary, optionally also contain one or more organic and / or inorganic pigments as UV filter substances, which may be present in the water and / or the oil phase
Erfindungsgemäß sind alle Ausführungsformen, bei denen sich die UV-Schutzsubstanzen ausschließlich in einer der beiden Phasen oder in beiden Phasen der erfindungsgemäßen Zubereitung befinden.According to the invention are all embodiments in which the UV protective substances are exclusively in one of the two phases or in both phases of the preparation according to the invention.
Besonders vorteilhafte bei Raumtemperatur flüssige UV-Filtersubstanzen im Sinne der vorliegenden Erfindung sind Homomenthylsalicylat (INCI: Homosalate), 2-Ethylhexyl-2- cyano-3,3-diphenylacrylat (INCI: Octocrylene), 2-Ethylhexyl-2-hydroxybenzoat (2-Ethyl- hexylsalicylat, Octylsalicylat, INCI: Ethylhexyl Salicylate) und Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure(2-ethylhexyl)ester (2-Ethylhexyl-4-methoxycinnamat, INCI: Ethylhexyl Methoxycinnamate) und 4-Methoxyzimtsäureisopentylester (lsopentyl-4- methoxycinnamat, INCI: Isoamyl p-Methoxycinnamate) und polymere UV-Filter wie das (3-(4-(2,2-bis-Ethoxycarbonylvinyl)-phenoxy) propenyl)- methylsiloxan/Dimethylsiloxan Copolymer, welches beispielsweise bei Hoffmann-La Röche unter der Handelsbezeichnung Parsol SLX erhältlich ist.Particularly advantageous UV filter substances which are liquid at room temperature for the purposes of the present invention are homomenthyl salicylate (INCI: homosalate), 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (INCI: octocrylene), 2-ethylhexyl-2-hydroxybenzoate (2- Ethyl hexyl salicylate, octyl salicylate, INCI: ethyl hexyl salicylate) and esters of cinnamic acid, preferably 4-methoxy cinnamic acid (2-ethyl hexyl) ester (2-ethyl hexyl 4-methoxy cinnamate, INCI: ethyl hexyl methoxy cinnamate) and 4-methoxy cinnamate (4-methoxy cinnamate) isophenoxy cinnamate , INCI: Isoamyl p-methoxycinnamate) and polymeric UV filters such as the (3- (4- (2,2-bis-ethoxycarbonylvinyl) -phenoxy) propenyl) methylsiloxane / dimethylsiloxane copolymer, which is available, for example, from Hoffmann-La Röche under the Trade name Parsol SLX is available.
Bevorzugte anorganische Pigmente sind Metalloxide und/oder andere in Wasser schwerlösliche oder unlösliche Metallverbindungen, insbesondere Oxide des Titans (TiO2), Zinks (ZnO), Eisens (z. B. Fe2O3), Zirkoniums (ZrO2), Siliciums (SiO2), Mangans (z. B. MnO), Aluminiums (AI2O3), Cers (z. B. Ce2O3), Mischoxide der entsprechenden Metalle sowie Abmischungen aus solchen Oxiden sowie das Sulfat des Bariums (BaSO4).Preferred inorganic pigments are metal oxides and / or other metal compounds which are sparingly soluble or insoluble in water, in particular oxides of titanium (TiO 2 ), zinc (ZnO), iron (e.g. Fe 2 O 3 ), zirconium (ZrO 2 ), silicon ( SiO 2 ), manganese (e.g. MnO), Aluminum (Al 2 O 3 ), cerium (e.g. Ce 2 O 3 ), mixed oxides of the corresponding metals as well as mixtures of such oxides and the sulfate of barium (BaSO 4 ).
Die Pigmente können vorteilhaft im Sinne der vorliegenden Erfindung auch in Form kommerziell erhältlicher öliger oder wässriger Vordispersionen zur Anwendung kommen. Diesen Vordispersionen können vorteilhaft Dispergierhilfsmittel und/oder Solubilisations- vermittler zugesetzt sein.For the purposes of the present invention, the pigments can also advantageously be used in the form of commercially available oily or aqueous predispersions. Dispersing aids and / or solubilizing agents can advantageously be added to these predispersions.
Die Pigmente können erfindungsgemäß vorteilhaft oberflächlich behandelt („gecoatet") sein, wobei beispielsweise ein hydrophiler, amphiphiler oder hydrophober Charakter gebildet werden bzw. erhalten bleiben soll. Diese Oberflächenbehandlung kann darin bestehen, daß die Pigmente nach an sich bekannten Verfahren mit einer dünnen hydrophilen und/oder hydrophoben anorganischen und/oder organischen Schicht versehen werden. Die verschiedenen Oberflächenbeschichtungen können im Sinne der vorliegenden Erfin- düng auch Wasser enthalten.According to the invention, the pigments can advantageously be surface-treated ("coated"), for example, a hydrophilic, amphiphilic or hydrophobic character should be formed or retained. This surface treatment can consist in that the pigments are prepared using a thin hydrophilic and / or hydrophobic inorganic and / or organic layer The various surface coatings can also contain water in the sense of the present invention.
Anorganische Oberflächenbeschichtungen im Sinne der vorliegenden Erfindung können bestehen aus Aluminiumoxid (AI2O3), Aluminiumhydroxid AI(OH)3, bzw. Aluminiumoxidhydrat (auch: Alumina, CAS-Nr.: 1333-84-2), Natriumhexa etaphosphat (NaPO3)6, Natriummetaphosphat (NaPO3)n, Siliciumdioxid (SiO2) (auch: Silica, CAS-Nr.: 7631-86-9), Bariumsulfat (BaSO4) oder Eisenoxid (Fe2O3). Diese anorganischen Oberflächenbeschichtungen können allein, in Kombination und/oder in Kombination mit organischen Beschichtungsmaterialien vorkommen.Inorganic surface coatings in the sense of the present invention can consist of aluminum oxide (Al 2 O 3 ), aluminum hydroxide Al (OH) 3 , or aluminum oxide hydrate (also: alumina, CAS no .: 1333-84-2), sodium hexa etaphosphate (NaPO 3 ) 6 , sodium metaphosphate (NaPO 3 ) n , silicon dioxide (SiO 2 ) (also: silica, CAS No .: 7631-86-9), barium sulfate (BaSO 4 ) or iron oxide (Fe 2 O 3 ). These inorganic surface coatings can occur alone, in combination and / or in combination with organic coating materials.
Organische Oberflächenbeschichtungen im Sinne der vorliegenden Erfindung können bestehen aus pflanzlichem oder tierischem Aluminiumstearat, pflanzlicher oder tierischer Stearinsäure, Laurinsäure, Dimethylpolysiloxan (auch: Dimethicone), Methylpolysiloxan (Methicone), Simethicone (einem Gemisch aus Dimethylpolysiloxan mit einer durchschnittlichen Kettenlänge von 200 bis 350 Dimethylsiloxan-Einheiten und Silicagel) oder Alginsäure. Diese organischen Oberflächenbeschichtungen können allein, in Kombination und/oder in Kombination mit anorganischen Beschichtungsmaterialien vorkommen.Organic surface coatings in the sense of the present invention can consist of vegetable or animal aluminum stearate, vegetable or animal stearic acid, lauric acid, dimethylpolysiloxane (also: dimethicone), methylpolysiloxane (methicone), simethicone (a mixture of dimethylpolysiloxane with an average chain length of 200 to 350 dimethylsiloxane Units and silica gel) or alginic acid. These organic surface coatings can occur alone, in combination and / or in combination with inorganic coating materials.
Erfindungsgemäß geeignete Zinkoxidpartikel und Vordispersionen von Zinkoxidpartikeln sind unter folgenden Handelsbezeichnungen bei den aufgeführten Firmen erhältlich: Zinc oxide particles and predispersions of zinc oxide particles suitable according to the invention are available under the following trade names from the listed companies:
Figure imgf000014_0001
Figure imgf000014_0001
Geeignete Titandioxidpartikel und Vordispersionen von Titandioxidpartikeln sind unter folgenden Handelsbezeichnungen bei den aufgeführten Firmen erhältlich:Suitable titanium dioxide particles and predispersions of titanium dioxide particles are available under the following trade names from the companies listed:
Figure imgf000014_0002
Figure imgf000014_0002
Vorteilhafte UV-A-Filtersubstanzen im Sinne der vorliegenden Erfindung sind Dibenzoyl- methanderivate, insbesondere das 4-(tert.-Butyl)-4'-methoxydibenzoylmethan (CAS-Nr. 70356-09-1), welches von Givaudan unter der Marke Parsol® 1789 und von Merck unter der Handelsbezeichnung Eusolex® 9020 verkauft wird.Advantageous UV-A filter substances for the purposes of the present invention are dibenzoyl methane derivatives, in particular 4- (tert-butyl) -4'-methoxydibenzoyl methane (CAS No. 70356-09-1), which is available from Givaudan under the Parsol brand ® 1789 and is sold by Merck under the trade name Eusolex® 9020.
Vorteilhafte weitere UV-Filtersubstanzen im Sinne der vorliegenden Erfindung sind-sulfo- nierte, wasserlösliche UV-Filter, wie z. B.:Advantageous further UV filter substances for the purposes of the present invention are sulfonated, water-soluble UV filters, such as, for. B .:
• Phenylen-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonsäure und ihre Salze, beson- ders die entsprechenden Natrium-, Kalium- oder Triethanolammonium-Salze, insbesondere das Phenylen-1 ,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonsäure-bis-natri- umsalz mit der INCI-Bezeichnung Disödium Phenyl Dibenzimidazole Tetrasulfonate (CAS-Nr.: 180898-37-7), welches beispielsweise unter der Handelsbezeichnung Neo Heliopan AP bei Haarmann & Reimer erhältlich ist; • Salze der 2-Phenylbenzimidazol-5-sulfonsäure, wie ihr Natrium-, Kalium- oder ihr Tri- ethanolammonium-Salz sowie die Sulfonsäure selbst mit der INCI Bezeichnung Phe- nylbenzimidazole Sulfonsäure (CAS.-Nr. 27503-81-7), welches beispielsweise unter der Handelsbezeichnung Eusolex 232 bei Merck oder unter Neo Heliopan Hydro bei Haarmann & Reimer erhältlich ist;• Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid and its salts, especially the corresponding sodium, potassium or triethanolammonium salts, especially phenylene-1 , 4-bis- (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid bis-sodium salt with the INCI name Disödium Phenyl Dibenzimidazole Tetrasulfonate (CAS no .: 180898-37-7), which is available, for example, from Haarmann & Reimer under the trade name Neo Heliopan AP; • Salts of 2-phenylbenzimidazole-5-sulfonic acid, such as its sodium, potassium or triethanolammonium salt and the sulfonic acid itself with the INCI name phenylbenzimidazole sulfonic acid (CAS No. 27503-81-7), which for example under the trade name Eusolex 232 is available from Merck or from Neo Heliopan Hydro from Haarmann &Reimer;
• 1 ,4-di(2-oxo-10-Sulfo-3-bomylidenmethyl)-Benzol (auch: 3,3'-(1 ,4-Phenylendimethy- lene)-bis-(7,7-dimethyl-2-oxo-bicyclo-[2.2.1]hept-1-ylmethan Sulfonsäure) und des- sen Salze (besonders die entsprechenden 10-Sulfato-verbindungen, insbesondere das entsprechende Natrium-, Kalium- oder Triethanolammonium-Salz), das auch als Benzol-1,4-di(2-oxo-3-borny!idenmethyl-10-sulfonsäure) bezeichnet wird. Benzol-1,4- di(2-oxo-3-bomylidenmethyl-10-sulfonsäure) hat die INCI-Bezeichnung Terephtali- dene Dicampher Sulfonsäure (CAS.-Nr.: 90457-82-2) und ist beispielsweise unter dem Handelsnamen Mexoryl SX von der Fa. Chimex erhältlich;1,4-di (2-oxo-10-sulfo-3-bomylidene-methyl) -benzene (also: 3,3 '- (1,4-phenylenedimethylene)) -bis- (7,7-dimethyl-2- oxo-bicyclo- [2.2.1] hept-1-ylmethane sulfonic acid) and its salts (especially the corresponding 10-sulfato compounds, in particular the corresponding sodium, potassium or triethanolammonium salt), which is also called benzene 1,4-di (2-oxo-3-borny! Idenmethyl-10-sulfonic acid) is called Benzene-1,4-di (2-oxo-3-bomylidenemethyl-10-sulfonic acid) has the INCI name terephthalic the dicampher sulfonic acid (CAS No. 90457-82-2) and is available, for example, from the company Chimex under the trade name Mexoryl SX;
• Sulfonsäure-Derivate des 3-Benzylidencamphers, wie z. B. 4-(2-Oxo-3-bornyliden- methyl)benzolsulfonsäure, 2-Methyl-5-(2-oxo-3-bomylidenmethyl)sulfonsäure und deren Salze.• Sulfonic acid derivatives of 3-benzylidene camphor, such as. B. 4- (2-oxo-3-bornylidene-methyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bomylidene-methyl) sulfonic acid and salts thereof.
• Hydroxybenzophenon-Derivate, wie z.B. 2-(4-Diethylamino-2-hydroxybenzoyl)- benzoic acid hexylester, welches beispielsweise von der Firma BASF unter demHydroxybenzophenone derivatives, such as e.g. 2- (4-Diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester, which is available, for example, from BASF under the
Handejsnamen Uvinul® A Plus erhältlich ist.Commercial name Uvinul® A Plus is available.
• Benzoxazol-Derivate, wie z.B. das 2,4-bis-[5-1(dimethylpropyl)benzossazol-2-yl-(4- phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazine (CAS-Nr.: 288254-16-0), welches beispielsweise unter dem Handelsnamen UVASorb® K2A von der Firma 3V Sigma erhältlich ist.Benzoxazole derivatives, such as e.g. the 2,4-bis- [5-1 (dimethylpropyl) benzossazol-2-yl- (4-phenyl) imino] -6- (2-ethylhexyl) imino-1,3,5-triazine (CAS no .: 288254-16-0), which is available, for example, from 3V Sigma under the trade name UVASorb® K2A.
Vorteilhafte UV-Filtersubstanzen im Sinne der vorliegenden Erfindung sind ferner sogenannte Breitbandfilter, d.h. Filtersubstanzen, die sowohl UV-A- als auch UV-B-Strahlung absorbieren.Advantageous UV filter substances in the sense of the present invention are also so-called broadband filters, i.e. Filter substances that absorb both UV-A and UV-B radiation.
Vorteilhafte Breitbandfilter oder UV-B-Filtersubstanzen sind beispielsweise Triazinderi- vate, wie z. B.Advantageous broadband filters or UV-B filter substances are, for example, triazine derivatives, such as. B.
• 2,4-Bis-{[4-(2-Ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyρhenyl)-1 ,3,5-triazin (INCI: Aniso Triazin), welches unter der Handelsbezeichnung Tinosorb® S bei der CIBA-Chemikalien GmbH erhältlich ist;• 2,4-bis - {[4- (2-ethylhexyloxy) -2-hydroxy] phenyl} -6- (4-methoxyρhenyl) -1, 3,5-triazine (INCI: Aniso Triazine), which is available from CIBA-Chemicals GmbH under the trade name Tinosorb® S;
• Diethylhexylbutylamidotriazon (INCI: Diethylhexylbutamidotriazone), welches unter der Handelsbezeichnung UVASORB HEB bei Sigma 3V erhältlich ist;• Diethylhexylbutylamidotriazon (INCI: Diethylhexylbutamidotriazone), which is available under the trade name UVASORB HEB from Sigma 3V;
• 4,4',4"-(1,3,5-Triazin-2,4,6-triyltriimino)-tris-benzoesäure-tris(2-ethylhexylester), auch: 2,4,6-Tris-[anilino-(p-carbo-2'-ethyl-1'-hexyloxy)]-1 ,3,5-triazin (INCI: Ethylhexyl Tria- zone), welches von der BASF Aktiengesellschaft unter der Warenbezeichnung UVINUL® T 150 vertrieben wird.• 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) -tris-benzoic acid tris (2-ethylhexyl ester), also: 2,4,6-tris [anilino - (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl tria- zone), which is sold by BASF Aktiengesellschaft under the trade name UVINUL® T 150.
Ein vorteilhafter Breitbandfilter im Sinne der vorliegenden Erfindung ist auch das 2,2'-Me- thylen-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)-phenol), welches unter der Handelsbezeichnung Tinosorb® M bei der CIBA-Chemikalien GmbH erhältlich ist.An advantageous broadband filter in the sense of the present invention is also the 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol ), which is available under the trade name Tinosorb® M from CIBA-Chemicals GmbH.
Vorteilhafter Breitbandfilter im Sinne der vorliegenden Erfindung ist ferner das 2-(2H-ben- zotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3l3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxa- nyöpropylj-phenol (CAS-Nr.: 155633-54-8) mit der INCI-Bezeichnung Drometrizole Trisi- loxane, welches unter der Handelsbezeichnung Mexoryl® XL bei der Fa. Chimex erhältlich ist.Another advantageous broadband filter for the purposes of the present invention is 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1.3 l 3,3-tetramethyl-1- [(trimethylsilyl) oxy] disiloxa- nyöpropylj-phenol (CAS no .: 155633-54-8) with the INCI name Drometrizole Trisiloxane, which is available under the trade name Mexoryl® XL from Chimex.
Die weiteren UV-Filtersubstanzen können öllöslich oder wasserlöslich sein.The other UV filter substances can be oil-soluble or water-soluble.
Vorteilhafte öllösliche UV-B- und/oder Breitband-Filtersubstanzen im Sinne der vorliegenden Erfindung sind z. B.:Advantageous oil-soluble UV-B and / or broadband filter substances in the sense of the present invention are e.g. B .:
3-Benzylidencampher-Derivate, vorzugsweise 3-(4-Methylbenzyliden)campher, 3- Benzylidencampher, 4-Aminobenzoesäure-Derivate, vorzugsweise 4-(Dimethylamino)-benzoesäure(2- ethylhexyl)ester, 4-(Dimethylamino)benzoesäureamylester, 3-benzylidene camphor derivatives, preferably 3- (4-methylbenzylidene) camphor, 3-benzylidene camphor, 4-aminobenzoic acid derivatives, preferably 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester, 4- (dimethylamino) benzoic acid amyl ester,
Derivate des Benzophenons, vorzugsweise 2-Hydroxy-4-methoxybenzophenon, 2- Hydroxy-4-methoxy-4'-methylbenzophenon, 2,2'-Dihydroxy-4-methoxybenzophenon Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone
sowie an Polymere gebundene UV-Filter. 3-(4-(2,2-bis Ethoxycarbonylvinyl)-phenoxy)propenyl)-methoxysiloxan/Dimethylsiloxan - Copolymer welches beispielsweise unter der Handelsbezeichnung Parsol® SLX bei Hoffmann La Röche erhältlich ist. and UV filters bound to polymers. 3- (4- (2,2-bis ethoxycarbonylvinyl) phenoxy) propenyl) -methoxysiloxan / dimethylsiloxane - copolymer which is obtainable for example under the trade name Parsol SLX from Hoffmann La Roche.
Besonders vorteilhafte Zubereitungen im Sinne der vorliegenden Erfindung, die sich durch einen hohen bzw. sehr hohen UV-A- und/oder UV-B-Schutz auszeichnen, enthalten neben der oder den erfindungsgemäßen Filtersubstanz(en) bevorzugt ferner weitere UV-A- und/oder Breitbandfilter, insbesondere Dibenzoylmethanderivate [beispielsweise das 4-(tert.-Butyl)-4'-methoxydibenzoylmethan], Phenylen-1 ,4-bis-(2- benzimidazyl)-3,3'-5,5'-tetrasulfonsäure und/oder ihre Salze, das 2-(4-Diethylamino-2- hydroxybenzoyl)-benzoic acid hexylester und/oder das 2,4-Bis-{[4-(2-Ethyl-hexyloxy)-2- hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazin und/oder das 2-(4-Diethylamino-2- hydroxybenzoyl)-benzoic acid hexylester, jeweils einzeln oder in beliebigen Kombinationen miteinander.Particularly advantageous preparations within the meaning of the present invention, which are distinguished by a high or very high UV-A and / or UV-B protection, preferably contain further UV-A and in addition to the filter substance (s) according to the invention / or broadband filter, in particular dibenzoylmethane derivatives [for example the 4- (tert-butyl) -4'-methoxydibenzoylmethane], phenylene-1,4, bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid and / or their salts, the 2- (4-diethylamino-2- hydroxybenzoyl) benzoic acid hexyl ester and / or the 2,4-bis - {[4- (2-ethylhexyloxy) -2-hydroxy] phenyl} -6- (4-methoxyphenyl) -1,3,5- triazine and / or the 2- (4-diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester, in each case individually or in any combination with one another.
Die Liste der genannten UV-Filter, die im Sinne der vorliegenden Erfindung eingesetzt werden können, soll selbstverständlich nicht limitierend sein.The list of UV filters mentioned, which can be used in the sense of the present invention, should of course not be limiting.
Die erfindungsgemäß vorteilhaften UV-Lichtschutzfilter werden bevorzugt in einer Konzentration von 0,1 bis 30 Gewichts-%, insbesondere in. einer Konzentration von 0,5 bis 15 Gewichts-%, bezogen auf das Gesamtgewicht der Formulierung, eingesetzt:The UV light protection filters advantageous according to the invention are preferably used in a concentration of 0.1 to 30% by weight, in particular in a concentration of 0.5 to 15% by weight, based on the total weight of the formulation:
Besonders bevorzugte Ausführungsformen der vorliegenden Erfindung enthalten als dass UV-Filter ein oder mehrere Triazin-Derivate, Dibenzoylmethanderivate, bei Raumtemperatur flüssigen UV-Filter und/oder der anorganisch Pigmente, insbesondere Titandioxid.Particularly preferred embodiments of the present invention contain, as the UV filter, one or more triazine derivatives, dibenzoylmethane derivatives, UV filters which are liquid at room temperature and / or the inorganic pigments, in particular titanium dioxide.
Ferner kann es gegebenenfalls von Vorteil sein, Filmbildner in die erfindungsgemäße Zubereitung einzuarbeiten, beispielsweise um die Wasserfestigkeit der Zubereitungen zu verbessern oder die UV-Schutzleistung zu erhöhen (UV-A- und/oder UV-B-Boosting). Geeignet sind sowohl wasserlösliche bzw. dispergierbare als auch fettlösliche Filmbildner, jeweils einzeln oder in Kombination miteinander.It may also be advantageous to incorporate film formers into the preparation according to the invention, for example in order to improve the water resistance of the preparations or to increase the UV protection performance (UV-A and / or UV-B boosting). Both water-soluble or dispersible and fat-soluble film formers are suitable, in each case individually or in combination with one another.
Vorteilhafte wasserlöslich bzw. dispergierbare Filmbildner sind z. B. Polyurethane (z. B. die Avalure® -Typen von Goodrich), Dimethicone Copolyol Polyacrylate (Silsoft Surface® von der Witco Organo Silicones Group), PVP/VA (VA = Vinylacetat) Copolymer (Luviscol VA 64 Powder der BASF) etc.Advantageous water-soluble or dispersible film formers are e.g. B. Polyurethanes (e.g. Avalure® types from Goodrich), Dimethicone Copolyol Polyacrylate (Silsoft Surface® from the Witco Organo Silicones Group), PVP / VA (VA = vinyl acetate) copolymer (Luviscol VA 64 Powder from BASF) etc ,
Vorteilhafte fettlösliche Filmbildner sind z. B., die Filmbildner aus der Gruppe der Poly- mere auf Basis von Polyvinylpyrrolidon (PVP)Advantageous fat-soluble film formers are e.g. B., the film formers from the group of polymers based on polyvinylpyrrolidone (PVP)
Figure imgf000017_0001
Besonders bevorzugt sind Copolymere des Polyvinylpyrrolidons, beispielsweise das PVP Hexadecen Copolymer und das PVP Eicosen Copolymer, welche unter den Handelsbezeichnungen Antaron V216 und Antaron V220 bei der GAF Chemicals Cooperation erhältlich sind, sowie das Tricontayl PVP und dergleichen mehr.
Figure imgf000017_0001
Particularly preferred are copolymers of polyvinylpyrrolidone, for example the PVP hexadecene copolymer and the PVP eicosen copolymer, which are available under the trade names Antaron V216 and Antaron V220 from GAF Chemicals Cooperation, as well as Tricontayl PVP and the like.
Erfindungsgemäß ist das Verfahren zur Einstellung der Auftrenngeschwindigkeit einer durch Schütteln homogenisierten erfindungsgemäßen zweiphasigen kosmetischen und/oder dermatologischen Zubereitung welches dadurch gekennzeichnet ist, dass die Dichtedifferenz der beiden Phasen variiert wird durch den Zusatz von a) ein oder mehreren Alkoholen zur wässrigen Phase, wodurch deren Dichte verringert wird, b) einem oder mehrerer Alkali- und/oder Erdalkalisalze organischer und/oder anorganischer Säuren zur wässrigen Phase, wodurch deren Dichte erhöht wird, c) Mineralölen, Dicaprylylether und/oder Octyldodecanol zur lipophilen Phase, wodurch deren Dichte verringert wir , und/oder d) Capryl-Caprinsäuretriglycerid, C12-15 Alkyl Benzoate, Dicarylylcarbonate und/oder Triisostearin, wodurch die Dichte der lipophilen Phase erhöht wird, wobei eine geringere Dichtedifferenz eine Verlängerung der Auftrenngeschwindigkeit zur Folge hat.According to the invention, the method for adjusting the separation speed of a two-phase cosmetic and / or dermatological preparation homogenized by shaking according to the invention is characterized in that the difference in density of the two phases is varied by the addition of a) one or more alcohols to the aqueous phase, thereby reducing their density is reduced, b) one or more alkali and / or alkaline earth metal salts of organic and / or inorganic acids to the aqueous phase, which increases their density, c) mineral oils, dicaprylyl ether and / or octyldodecanol to the lipophilic phase, which reduces their density, and / or d) Caprylic-capric triglyceride, C12-15 alkyl benzoates, dicarylyl carbonates and / or triisostearin, whereby the density of the lipophilic phase is increased, a lower density difference resulting in an increase in the separation rate.
Erfindungsgemäß wird unter der Auftrenngeschwindigkeit die Zeit verstanden, welche die durch Schütteln homogenisierte Zubereitung benötigt um sich optisch mit bloßem Auge sichtbar wieder in zwei durch eine eindeutige Phasengrenze voneinander abgetrennte Phasen zu entmischen.According to the invention, the separation speed is understood to mean the time which the preparation homogenized by shaking takes to visually separate into two phases separated from one another by a clear phase boundary, visually visible to the naked eye.
Die Auftrenngeschwindigkeit beträgt dabei erfindungsgemäß mindestens 1 Minute und maximal 45 Minuten.According to the invention, the separation speed is at least 1 minute and a maximum of 45 minutes.
Erfindungsgemäß entspricht dabei eine Dichtedifferenz von 2 bis 6 % einer Auftrenngeschwindigkeit von ca. 1 bis 15 Minuten und eine Dichtedifferenz von 0,1 bis 2 % einer Auftrenngeschwindigkeit von ca. 15 bis 45 Minuten.According to the invention, a density difference of 2 to 6% corresponds to a separation speed of approx. 1 to 15 minutes and a density difference of 0.1 to 2% corresponds to a separation speed of approx. 15 to 45 minutes.
Erfindungsgemäß vorteilhaft ist die Verwendung von einem oder mehreren Alkoholen in erfindungsgemäßen kosmetischen und/oder dermatologischen Zubereitungen zur Verlängerung der Auftrenngeschwindigkeit in zwei Phasen nach der Homogenisierung der Zubereitung durch Schütteln.According to the invention, the use of one or more alcohols in cosmetic and / or dermatological preparations according to the invention is advantageous Extension of the separation speed in two phases after homogenization of the preparation by shaking.
Erfindungsgemäß ist auch die Verwendung von einem oder mehrerer Alkali- und/oder Erdalkalisalze organischer und/oder anorganischer Säuren in erfindungsgemäßen kosmetischen und/oder dermatologischen Zubereitungen zur Verkürzung der Auftrenngeschwindigkeit in zwei Phasen nach der Homogenisierung der Zubereitung durch Schütteln.According to the invention, the use of one or more alkali and / or alkaline earth metal salts of organic and / or inorganic acids in cosmetic and / or dermatological preparations according to the invention to shorten the separation speed in two phases after the homogenization of the preparation by shaking.
Erfindungsgemäß ist außerdem die Verwendung von Mineralölen, Dicaprylylether und/oder Octyldodecanol in erfindungsgemäßen kosmetischen und/oder dermatologischen Zubereitungen zur Verlängerung der Auftrenngeschwindigkeit in zwei Phasen nach der Homogenisierung der Zubereitung durch Schütteln.According to the invention, the use of mineral oils, dicaprylyl ether and / or octyldodecanol in cosmetic and / or dermatological preparations according to the invention is also used to extend the separation rate in two phases after the preparation has been homogenized by shaking.
Erfindungsgemäß ist auch die Verwendung von Capryl-Caprinsäuretriglycerid und/oder Triisostearin in erfindungsgemäßen kosmetischen und/oder dermatologischen Zubereitungen zur Verkürzung der Auftrenngeschwindigkeit in zwei Phasen nach der Homogenisierung der Zubereitung durch Schütteln,According to the invention, the use of caprylic-capric triglyceride and / or triisostearin in cosmetic and / or dermatological preparations according to the invention is also used to shorten the separation speed in two phases after the preparation has been homogenized by shaking,
Vorteilhaft im Sinne der vorliegenden Erfindung ist die Verwendung von erfindungsgemäßen kosmetischen und/oder dermatologischen Zubereitungen zur Pflege der Haut und Hautanhanggebilde (z.B. der Haare, Nägel).For the purposes of the present invention, the use of cosmetic and / or dermatological preparations according to the invention for the care of the skin and skin appendages (e.g. the hair, nails) is advantageous.
Vorteilhaft im Sinne der vorliegenden Erfindung ist die Verwendung kosmetischen und/oder dermatologischen Zubereitungen nach einem der vorhergehenden Ansprüche zur Reinigung der Haut und Hautanhanggebilde.For the purposes of the present invention, the use of cosmetic and / or dermatological preparations according to one of the preceding claims is advantageous for cleaning the skin and skin appendages.
Erfindungsgemäß bevorzugt ist die Verwendung der erfindungsgemäßen Zubereitungen zum Kühlen und Erfrischen (engl. Cooling / Refreshing) der Haut.According to the invention, the use of the preparations according to the invention for cooling and refreshing the skin is preferred.
Erfindungsgemäß bevorzugt ist auch die Aufbewahrung (Verpackung) der erfindungsgemäßen Zubereitungen in transparenten oder transluzenten Verpackungen. Die nachfolgenden Beispiele sollen die vorliegende Erfindung verdeutlichen, ohne sie einzuschränken. Alle Mengenangaben, Anteile und Prozentanteile sind, soweit nicht anders angegeben, auf das Gewicht und die Gesamtmenge bzw. auf das Gesamtgewicht der Zubereitungen bezogen.The storage (packaging) of the preparations according to the invention in transparent or translucent packaging is also preferred according to the invention. The following examples are intended to illustrate the present invention without restricting it. Unless otherwise stated, all quantities, proportions and percentages are based on the weight and the total amount or on the total weight of the preparations.
Figure imgf000020_0001
Figure imgf000020_0001

Claims

Patentansprüche claims
1. Zweiphasige kosmetische und/oder dermatologische Zubereitung enthaltend a) eine wässrige Phase enthaltend i) ein oder mehrere Alkohole in einer Menge von mindestens 50 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung und ii) ein oder mehrere Alkali- und/oder Erdalkalisalze organischer und/oder anorganischer Säuren in einer Menge von 0,01 bis 6 Gewichts-%, bezogen auf das1. Two-phase cosmetic and / or dermatological preparation containing a) an aqueous phase containing i) one or more alcohols in an amount of at least 50% by weight, based on the total weight of the preparation and ii) one or more alkali and / or alkaline earth metal salts organic and / or inorganic acids in an amount of 0.01 to 6% by weight, based on the
Gesamtgewicht der Zubereitung b) eine Lipidphase deren Grenzflächenspannung mindestens 30 Nm/m beträgt, neben gegebenenfalls weiteren kosmetischen und/oder dermatologischen Wirk-,Total weight of the preparation b) a lipid phase whose interfacial tension is at least 30 Nm / m, in addition to any other cosmetic and / or dermatological active ingredients,
Hilfs- und Zusatzstoffen. 2. Zweiphasige kosmetische und/oder dermatologische Zubereitung nach Anspruch 1, dadurch gekennzeichnet, dass ein oder mehrere Alkohole gewählt werden aus der Gruppe Ethanol, 1-Propanol, Auxiliaries and additives. 2. Two-phase cosmetic and / or dermatological preparation according to claim 1, characterized in that one or more alcohols are selected from the group consisting of ethanol, 1-propanol,
2-Propanol.2-propanol.
3. Zweiphasige kosmetische und/oder dermatologische Zubereitung nach einem der Ansprüche t oder 2, dadurch gekennzeichnet, dass ein oder mehrere Alkali- und/oder Erdalkalisalze organischer und/oder anorganischer Säuren gewählt werden aus der Gruppe Magnesiumchlorid, Natriumchlorid, Kaliumchlorid, Calciumchlorid, Magnesiumchlorid, Meersalz.3. Two-phase cosmetic and / or dermatological preparation according to one of claims t or 2, characterized in that one or more alkali and / or alkaline earth salts of organic and / or inorganic acids are selected from the group magnesium chloride, sodium chloride, potassium chloride, calcium chloride, magnesium chloride , Sea-salt.
4. Verfahren zur Einstellung der Auftrenngeschwindigkeit einer durch Schütteln homogenisierten zweiphasigen kosmetischen und/oder dermatologischen Zubereitung nach einem der Ansprüche 1 bis 3, dadurch gekennzeichnet, dass die Dichtedifferenz der beiden Phasen variiert wird durch den Zusatz von a) ein oder mehreren Alkoholen zur wässrigen Phase, wodurch deren Dichte verringert wird, b) einem oder mehrerer Alkali- und/oder Erdalkalisalze organischer und/oder anorganischer Säuren zur wässrigen Phase, wodurch deren Dichte erhöht wird, c) Mineralölen, Dicaprylylether und/oder Octyldodecanol zur lipophilen Phase, . wodurch deren Dichte verringert wird, und/oder d) Capryl-Caprinsäuretriglycerid, C12-15 Alkyl Benzoate, Dicaprylylcarbonate und/oder Triisostearin, wodurch die Dichte der lipophilen Phase erhöht wird, wobei eine geringere Dichtedifferenz eine Verlängerung der Auftrenngeschwindigkeit zur Folge hat. 4. A method for adjusting the separation speed of a two-phase cosmetic and / or dermatological preparation homogenized by shaking according to one of claims 1 to 3, characterized in that the density difference of the two phases is varied by the addition of a) one or more alcohols to the aqueous phase , which reduces their density, b) one or more alkali and / or alkaline earth metal salts of organic and / or inorganic acids to the aqueous phase, thereby increasing their density, c) mineral oils, dicaprylyl ether and / or octyldodecanol to the lipophilic phase,. thereby reducing their density, and / or d) caprylic-capric triglyceride, C12-15 alkyl benzoates, dicaprylyl carbonates and / or triisostearin, which increases the density of the lipophilic phase, a lower density difference resulting in an increase in the separation rate.
5. Verwendung von einem oder mehreren Alkoholen in kosmetischen und/oder dermatologischen Zubereitungen nach einem der vorhergehenden Ansprüche zur Verlängerung der Auftrenngeschwindigkeit in zwei Phasen nach der Homogenisierung der Zubereitung durch Schütteln. 5. Use of one or more alcohols in cosmetic and / or dermatological preparations according to one of the preceding claims for extending the separation speed in two phases after the homogenization of the preparation by shaking.
6. Verwendung von einem oder mehrerer Alkali- und/oder Erdalkalisalze organischer und/oder anorganischer Säuren in kosmetischen und/oder dermatologischen Zubereitungen nach einem der vorhergehenden Ansprüche zur Verkürzung der Auftrenngeschwindigkeit in zwei Phasen nach der Homogenisierung der Zubereitung durch Schütteln. 6. Use of one or more alkali and / or alkaline earth metal salts of organic and / or inorganic acids in cosmetic and / or dermatological preparations according to one of the preceding claims to shorten the separation speed in two phases after the homogenization of the preparation by shaking.
7. Verwendung von Mineralölen, Dicaprylylether und/oder Octyldodecanol in kosmetischen und/oder dermatologischen Zubereitungen nach einem der vorhergehenden Ansprüche zur Verlängerung der Auftrenngeschwindigkeit in zwei Phasen nach der Homogenisierung der Zubereitung durch Schütteln.7. Use of mineral oils, dicaprylyl ether and / or octyldodecanol in cosmetic and / or dermatological preparations according to one of the preceding claims for extending the separation speed in two phases after the homogenization of the preparation by shaking.
8. Verwendung von Capryl-Caprinsäuretriglycerid, C12-15 Alkyl Benzoate, Dicapylylcarbonate und/oder Triisostearin in kosmetischen und/oder dermatologischen Zubereitungen nach einem der vorhergehenden Ansprüche zur Verkürzung der Auftrenngeschwindigkeit in zwei Phasen nach der Homogenisierung der Zubereitung durch Schütteln.8. Use of caprylic-capric triglyceride, C12-15 alkyl benzoate, dicapylyl carbonate and / or triisostearin in cosmetic and / or dermatological preparations according to one of the preceding claims to shorten the separation speed in two phases after the homogenization of the preparation by shaking.
9. Verwendung von kosmetischen und/oder dermatologischen Zubereitungen nach einem der vorhergehenden Ansprüche zur Reinigung und Pflege der Haut und9. Use of cosmetic and / or dermatological preparations according to one of the preceding claims for cleaning and care of the skin and
Hautanhanggebilde.Skin appendages.
10. Verwendung kosmetischen und/oder dermatologischen Zubereitungen nach einem der vorhergehenden Ansprüche zum Kühlen und Erfrischen der Haut. 10. Use of cosmetic and / or dermatological preparations according to one of the preceding claims for cooling and refreshing the skin.
PCT/EP2003/007733 2002-08-02 2003-07-16 Cosmetic preparations having two phases WO2004014325A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10235422.7 2002-08-02
DE2002135422 DE10235422A1 (en) 2002-08-02 2002-08-02 Two-phase cosmetic or dermatological composition comprises an aqueous phase containing an alcohol and one or more alkali(ne earth) metal salts and a lipid phase with a defined interfacial tension

Publications (1)

Publication Number Publication Date
WO2004014325A1 true WO2004014325A1 (en) 2004-02-19

Family

ID=30128670

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/007733 WO2004014325A1 (en) 2002-08-02 2003-07-16 Cosmetic preparations having two phases

Country Status (2)

Country Link
DE (1) DE10235422A1 (en)
WO (1) WO2004014325A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3038514A1 (en) * 2015-07-07 2017-01-13 Laboratoires M&L TRANSPARENT BIPHASE COSMETIC COMPOSITION
WO2020104092A1 (en) * 2018-11-21 2020-05-28 Beiersdorf Ag Oil-containing facial care preparation
EP3700498A4 (en) * 2017-10-25 2021-07-07 L'oreal A composition for caring for skin, method and use thereof
WO2022021329A1 (en) * 2020-07-31 2022-02-03 L'oreal Composition for caring for the keratin materials and a method to use thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011004927A1 (en) 2011-03-01 2012-09-06 Beiersdorf Ag Cosmetic or dermatological multiphase composition comprises a water phase, an oil phase, a water-in-oil emulsifier, monohydric alcohol, silicone oil and an electrolyte
FR3007638B1 (en) * 2013-06-28 2015-08-07 Oreal BIPHASE COMPOSITION COMPRISING MAGNESIUM ACETATE
FR3033249B1 (en) 2015-03-06 2020-11-13 Developpement Industrialisation Et Promotion De Tech Avancees AQUEOUS SOLAR COSMETIC COMPOSITION WITHOUT SURFACTANTS

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2206048A (en) * 1987-06-23 1988-12-29 Boots Co Plc Multi-layer cosmetic composition
EP0494391A1 (en) * 1991-01-10 1992-07-15 Goldwell Aktiengesellschaft Two-phase cosmetic composition
US5720942A (en) * 1992-06-01 1998-02-24 Radical Products, Inc. Two-phase tanning compositions and methods relating thereto
WO1999023998A1 (en) * 1997-11-11 1999-05-20 Henkel Kommanditgesellschaft Auf Aktien Multiphase stick preparation
US6019991A (en) * 1998-01-23 2000-02-01 Chesebrough-Pond's Usa Co., Two-phase cosmetic composition
EP1108421A2 (en) * 1999-12-17 2001-06-20 Unilever Plc Multilayered foaming spray product

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA783534A (en) * 1965-06-15 1968-04-23 Unilever Limited Liquid detergent compositions
JPS5462329A (en) * 1977-10-27 1979-05-19 Kanebo Ltd Composition for two-phase cosmetics
GB9025711D0 (en) * 1990-11-27 1991-01-09 Beecham Group Plc Topical composition
FR2670385B1 (en) * 1990-12-12 1995-03-03 Oreal TWO PHASE LIQUID COSMETIC COMPOSITION CONTAINING AT LEAST ONE DIALKYLPHTHALATE, INSOLUBLE PARTICLES AND A DENSITY BALANCING AGENT.
FR2670384A1 (en) * 1990-12-12 1992-06-19 Oreal COSMETIC CLEANING LIQUID COMPOSITION WITH TWO PHASES, CONTAINING AT LEAST ONE DIALKYLPHTALATE.
DE4215502C2 (en) * 1992-05-12 1995-05-18 Kao Corp Gmbh Cosmetic agent
JP3273573B2 (en) * 1992-07-15 2002-04-08 花王株式会社 Two-phase cosmetics
FR2721210B1 (en) * 1994-06-17 1996-08-02 Oreal Cleaning composition containing lipid grains.
JPH0859446A (en) * 1994-08-23 1996-03-05 Kao Corp Protective cosmetic from ultraviolet rays
DE19521951A1 (en) * 1995-06-08 1996-12-12 Lancaster Group Ag Multiphase light stabilizer, method of preparation and application to the skin
FR2753090B1 (en) * 1996-09-06 1999-03-19 Oreal USE OF A BIPHASIC COMPOSITION FOR MAKE-UP REMOVAL OF MAKE-UP COMPOSITIONS WITHOUT TRANSFER
JP2000086433A (en) * 1998-09-04 2000-03-28 Kose Corp Water-based double layer type cosmetic
DE19855767A1 (en) * 1998-12-03 1999-12-23 Wella Ag Manually and reversibly emulsifiable hair- or scalp-treatment composition free of organic emulsifiers

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2206048A (en) * 1987-06-23 1988-12-29 Boots Co Plc Multi-layer cosmetic composition
EP0494391A1 (en) * 1991-01-10 1992-07-15 Goldwell Aktiengesellschaft Two-phase cosmetic composition
US5720942A (en) * 1992-06-01 1998-02-24 Radical Products, Inc. Two-phase tanning compositions and methods relating thereto
WO1999023998A1 (en) * 1997-11-11 1999-05-20 Henkel Kommanditgesellschaft Auf Aktien Multiphase stick preparation
US6019991A (en) * 1998-01-23 2000-02-01 Chesebrough-Pond's Usa Co., Two-phase cosmetic composition
EP1108421A2 (en) * 1999-12-17 2001-06-20 Unilever Plc Multilayered foaming spray product

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3038514A1 (en) * 2015-07-07 2017-01-13 Laboratoires M&L TRANSPARENT BIPHASE COSMETIC COMPOSITION
EP3700498A4 (en) * 2017-10-25 2021-07-07 L'oreal A composition for caring for skin, method and use thereof
US11642293B2 (en) 2017-10-25 2023-05-09 L'oreal Composition for caring for skin, method and use thereof
WO2020104092A1 (en) * 2018-11-21 2020-05-28 Beiersdorf Ag Oil-containing facial care preparation
WO2022021329A1 (en) * 2020-07-31 2022-02-03 L'oreal Composition for caring for the keratin materials and a method to use thereof

Also Published As

Publication number Publication date
DE10235422A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
EP2255781B1 (en) Cosmetic preparation containing glucosyl glycerides and powder
EP1423149A2 (en) Stabilisation of uv-sensitive active ingredients
DE102007024342A1 (en) Cosmetic preparation, useful e.g. to protect skin from aging, comprises 2,4-bis-((4-(2-ethyl-hexyloxy)-2-hydroxy)-phenyl)-6-(4-methoxyphenyl)-1,3,5-triazine, 2-ethylhexyl-2-cyano-3,3-diphenylacrylate and a polysiloxane copolymer
WO2005117825A1 (en) 2-phenylethyl benzoate in cosmetic water-in-oil emulsions
EP2099424B1 (en) Cosmetic formulation containing glucosyl glycerides and skin lightening agents
WO2004056333A1 (en) Cosmetic and dermatological light protective formulations with a content of particular uv filter substances and alkylnaphthalates
DE102006034530A1 (en) Cosmetic preparation, useful e.g. as day or night cream to protect the skin against lesions, aging, dryness, roughness, itching and age spots, comprises (2-hydroxyethyl) urea and glucosyl glyceride
WO2003066012A1 (en) Preparations containing diol
EP2485806B1 (en) Use of cetearyl sulfosuccinates in sunscreen preparations
EP2094234B1 (en) Cosmetic formulation containing glucosyl glycerides and urea
WO2003020235A2 (en) Stabilisation of oxidation-sensitive and uv-sensitive active ingredients
DE10155958A1 (en) Cosmetic and dermatological light protection formulations containing hydroxybenzophenones and alkyl naphthalates
WO2003020224A1 (en) Stabilisation of oxidation-sensitive and uv-sensitive active ingredients
WO2004014325A1 (en) Cosmetic preparations having two phases
EP1634623A2 (en) Fluid cosmetic sunscreen composition
EP2496309B1 (en) Cosmetic preparation containing cetearyl sulfocsuccinates and comprising liquid uv filters
EP2099426A1 (en) Cosmetic formulation having glucosyl glycerides and scented substances
DE202006005804U1 (en) Cosmetic preparation, useful in skin care products, comprise a combination of plant oils and hydrogenated plant oils
DE10241074A1 (en) Emulsions with microcellulose
DE10140546A1 (en) Cosmetic and dermatological light protection formulations containing oil-soluble UV filter substances and iminodisuccinic acid and / or their salts
DE102007024347A1 (en) Cosmetic formulation for protecting skin aging, particularly UV-induced skin aging, and for use as sun protective agents, comprises dihydropyridine ethyloxysulfate ester salt and ethylhexyloxyphenol methoxyphenyl triazine
DE102007024346A1 (en) Cosmetic formulation for protecting skin aging, particularly UV-induced skin aging, and for use in cosmetic sprays as sun protective agents, comprises dihydropyridine ethyloxysulfate ester salt and hydoxybenzoyl benzoic acid hexyl ester
DE10140547A1 (en) Photoprotective cosmetic or dermatological composition, e.g. useful for moisturizing the skin, comprises liquid UV filter and iminodisuccinic acid
EP2451433A2 (en) Perfumed cosmetic preparation containing glycyrrhetinic acid

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003784020

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003784020

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP